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ABSTRACT 
 
 
 This dissertation discusses mechanistic and structural studies of enzymes with 
unique features. The studies are focused on: (i) mechanistic investigation of a novel 
cysteine salvage pathway that involves a flavoenzyme-mediated Pummerer-type 
rearrangement; (ii) structural enzymology of the superoxide radical-mediated catabolism 
of riboflavin; and (iii) mechanistic studies on a radical-mediated fragmentation-
recombination reaction catalyzed by Tryptophan Lyase (NosL).  
 Amino acid cysteine and its metabolites play a vital role in all forms of life. 
Recently, a pathway was identified in Bacillus subtilis that salvages cysteine from S-
substituted cysteines. We have reconstituted all five enzymes involved in this 
transformation. Detailed biochemical studies were performed on a unique Pummerer-
type rearrangement catalyzed by a flavin monooxygenase, CmoJ. Though the pathway 
shows broad substrate specificity, we have identified the physiological substrates of the 
enzymes. This study provides insights into a novel pathway that extracts sulfur from the 
organosulfur molecules in the largely unexplored world of rhizosphere microbiome. 
 In contrast to the biosynthesis of cofactors, their catabolism is scantly described in 
literature. The first riboflavin catabolic pathway was recently identified in Begley lab in 
2013. Mechanistic investigation using biochemical studies revealed that flavin 
mononucleotide (FMN) dependent Riboflavin Lyase (RcaE) utilizes a superoxide radical 
to catabolize riboflavin. Crystal structure of RcaE was solved at 1.75 Å, bound with 
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cofactor FMN and substrate riboflavin. Orientations of these ligands in the active site 
demonstrate that stacking of the riboflavin on top of FMN prevents the formation of 
typically observed C4a-flavin(hydro)peroxide. This structural study provides insights into 
a new class of flavin-dependent enzymes. 
 Tryptophan Lyase (NosL) is a radical SAM enzyme that catalyzes the formation of 
3-methyl-2-indolic acid from L-tryptophan. As suggested by the recent crystal structure 
of NosL, we have obtained biochemical evidence for H-atom abstraction from the amino 
group of L-tryptophan. Further experiments demonstrate that the subsequent β-scission 
involves Cα-C(O) cleavage. A mechanistic proposal is discussed that incorporates all 
latest discoveries, including the newly identified byproducts of the NosL catalyzed 
reaction. Additional studies with substrate analogs as well as mutants demonstrate a 
cornucopia of reactions with the 5′-deoxyadenosyl radical, which initiates chemistry in 
all radical SAM enzymes. 
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NOMENCLATURE 
 
5′tA 5′-deoxy-5′-thioadenosine 
Ado 5′-deoxyadenosyl radical 
Ado-H 5′-deoxyadeosine 
ATP Adenosine triphosphate 
BDE Bond dissociation energy 
BLAST Basic Local Alignment Search Tool 
BSTFA N,O-Bis(trimethylsilyl)trifluoroacetamide 
CIP Calf intestinal phosphatase 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DTNB 5,5′-dithio-bis-(2-nitrobenzoic acid) Ellman’s reagent 
DTT Dithiothreitol 
EIC Extracted Ion Chromatogram 
EPR Electron Paramagnetic Resonance 
FMN Flavin mononucleotide 
Fre Flavin reductase form E.coli 
GC-MS Gas Chromatography-Mass Spectrometry 
HPLC High Performance Liquid Chromatography 
kda kilodalton 
KPi Potassium phosphate 
  x 
LC-MS Liquid Chromatography-Mass Spectrometry 
MsrA Methionine sulfoxide reductase A 
MTA Methylthioadenosine 
NAD+ Nicotinamide adenine dinucleotide (oxidized form) 
NADH Nicotinamide adenine dinucleotide (reduced form) 
NCBI National Center for Biotechnology Information 
NMR Nuclear Magnetic Resonance 
NosL Tryptophan Lyase 
OD600 Optical density at 600 nm 
PDB Protein Data Bank 
PFBHA o-(2,3,4,5,6-pentafluorobenzyl)-hydroxylamine 
PLP Pyridoxal-5′-phosphate 
RBF Riboflavin 
RcaE Riboflavin Lyase 
RNA Ribonucleic acid 
RT Room temperature 
SAM S-Adenosyl-L-methionine 
TCEP Tris(2-carboxyethyl)phosphine 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
Tris Tris(hydroxymethyl)aminomethane 
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1. INTRODUCTION 
 
1.1 Introduction to cofactors1 
 Cofactors assist enzymes in catalyzing reactions. They can either be organic or 
inorganic in nature. They are either bound to the enzyme covalently or held by non-
covalent interactions. They are found ubiquitously in all forms of life and play a critical 
role in several key transformations.2 A subset of cofactors which we cannot 
biosynthesize and are supplemented through our diet are called vitamins. Lack of these 
vitamins can lead to debilitating diseases and even result in death. There has been 
tremendous progress in the past century to understand the role of cofactors at the 
molecular level. 
 
1.2 Flavins 
 Flavins are yellow chromophore found in various food sources like meat, eggs, 
dairy products, whole grains and dark green-vegetables. Alexander Wynter Blyth 
originally discovered flavins in milk as a yellow-green pigment in 1872.3 Further studies 
in 1934 by Paul Karrer and Richard Kuhn elucidated its structure and the yellow 
chromophore was named riboflavin (1, RBF). As shown in Figure 1.1, the 
physiologically active forms of flavins that act as cofactors include flavin 
mononucleotide (2, FMN) and flavin adenine dinucleotide (3, FAD).4  
Flavins are versatile cofactors that consist of a three membered 7,8-dimethyl-
isoalloxazine moiety, which is central to its activity.5 They can exist in multiple redox 
  2 
states, undergo reaction with O2, form covalent intermediates, transport electrons, etc. 
Deficiency of riboflavin can manifest in conditions like night blindness, migraines, 
anemia, fatigue, scaly skin, growth abnormalities in infants, etc.6 
 
 
 
 
Figure 1.1: Structure of RBF (1), its biologically active forms FMN (2) and FAD (3). 
 
 
 
1.3 S-Adenosyl-L-methionine (4, SAM) 
 S-adenosyl-L-methionine (4) is an essential sulfonium compound that is involved 
in many biochemical processes.7 It has been studied extensively since its chemical 
structure was first described in 1951.8 In many cases, SAM acts as a biological methyl 
donor, which can affect diverse processes like expression of genes and hormones, fetal 
development, brain function, etc.9 In addition to its methyl donor activity, SAM also acts 
as a substrate in biosynthesis of key compounds such as cyclopropanes, modified tRNA 
basepairs, N-acylhomoserine lactone, etc.7  
 In 2001, enzymes that utilize [4Fe-4S] and SAM to perform radical mediated 
transformations were classified into a new enzyme superfamily.10 Due to exponential 
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growth in availability of genome sequences in the last decade, this enzyme family 
currently includes more than 165,000 members.11 In this superfamily, the first step 
involves the transfer of an electron from [4Fe-4S] to the sulfonium group of SAM, 
which leads to the formation 5′-deoxyadenosyl radical (6, Figure 1.2A). This highly 
reactive oxidant typically abstracts a H-atom from the substrates, which further undergo 
complex transformations to generate products that would be inaccessible without radical 
chemistry.12 Figure 1.2B shows the remarkable range of reactions observed with organic 
radicals, most of which have also been observed with radical SAM enzymes. These 
include H-atom abstractions, addition to double bonds and β-bond scission reactions.13 
 
 
 
 
Figure 1.2: Radical mediated chemistry. A) In radical SAM enzymes, reductive 
homolytic cleavage of 4 generates 6. B) Examples of major transformations observed in 
organic radical chemistry. i) Hydrogen atom abstraction. ii) Addition to double bonds. 
iii-v) β-bond scission reactions. 
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1.4 Research opportunity 
 Recently, a pathway was found to be upregulated in Bacillus subtilis that 
salvages cysteine from S-substituted cysteines (7) in absence of a direct sulfur source in 
growth media.14 The pathway consists of transporter and transmembrane proteins that 
will help in uptake of organosulfur molecules present in the environment. All previously 
identified pathways of sulfur assimilation from organosulfur metabolites involve 
oxidation of sulfur to sulfite, while the unique feature of this pathway is that it liberates 
L-cysteine (8, Figure 1.3). The sulfur from L-cysteine (8) can be mobilized to meet the 
intra cellular needs of sulfur. Interestingly, this pathway generates a reduced form of 
sulfur even though it consists two flavin dependent mono-oxygenases. Identifying the 
roles of all enzymes in this pathway will delineate the intermediates and give insights on 
the strategy evolved by nature to perform a C-S lyase reaction using two flavin mono-
oxygenase enzymes. 
 
 
 
 
Figure 1.3: Conversion of S-substituted cysteine (7) to L-cysteine (8) in B.subtilis.  
 
 
 
  Pathways involved in catabolism of riboflavin were reported in literature in the 
mid 20th century.15-17 However, most of the strains were lost and enzymes involved in 
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the transformation were never identified.18 The first gene cluster involved in catabolism 
of riboflavin (1) was recently identified in the Begley lab.19 Further biochemical studies 
on enzymes in the pathway demonstrated that a flavin dependent enzyme (named 
Riboflavin Lyase, RcaE) catalyzed superoxide radical (9) mediated conversion of 
riboflavin (1) to lumichrome (11) and ribose (12, Figure 1.4). RcaE is the first reported 
example in flavin enzymology where the superoxide radical (9) catalyzed H-atom 
abstraction from substrate has been thoroughly demonstrated (manuscript under review). 
Structural studies on RcaE will illustrate the unique features this enzyme has evolved to 
catalyze a new class of flavin-mediated chemistry.  
 
 
 
 
Figure 1.4: RcaE catalyzed superoxide radical (9) mediated conversion of riboflavin (1) 
to lumichrome (11) and ribose (12). 
 
 
 
 Tryptophan Lyase (NosL) is encoded in the biosynthetic pathway of antibiotic 
nosiheptide.20 NosL is a radical SAM enzyme that catalyzes the conversion of L-
tryptophan (13) to an unusual compound 3-methyl-2-indolic acid (15, Figure 1.5).21 
Based on sequence analysis, NosL is classified into the aromatic amino acid lyase 
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family, which includes enzymes like ThiH, HydG and CofH.13 Recently published 
structure of NosL bound to substrate and cofactor suggests that the 5′-deoxadenosyl 
radical (6) abstracts H-atom from the amino group of L-tryptophan (13) instead of 
indolic N-H as previously proposed in the literature.22 Further experiments would 
unravel the mechanistic details of the unprecedented fragmentation-recombination 
reaction catalyzed by NosL. 
 
 
 
 
Figure 1.5: NosL catalyzed conversion of L-tryptophan (13) to 3-methyl-2-indolic acid 
(15) might progress through H-atom abstraction from amino group of 13. 
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2. FLAVIN MEDIATED CYSTEINE SALVAGE PATHWAY 
 
2.1 Role of sulfur in living organisms23 
Sulfur is the sixth most abundant element in living organisms followed by 
hydrogen, carbon, oxygen, nitrogen and phosphorus. Sulfur is essential for all living 
organisms and is required for the formation of many proteins, enzymes, cofactors and 
other metabolites. It plays a critical role in many catalytic and electrochemical processes 
in cells. Sulfur containing metabolites like glutathione or bacillithiol function as 
intracellular reducing agents and prevent damages that can be caused by reactive oxygen 
species. The high-energy sulfonium metabolite SAM (4) serves as a universal methyl 
donor,24 while Fe-S clusters play a crucial role in redox chemistry.25 Sulfur is also a 
component of life saving antibiotics like penicillin and cephalosporin.26 
Bacteria obtain sulfur from multiple sources in environment.27 These include 
inorganic sources like sulphates, thiosulphates or sulfites as well as organic sources like 
cysteine, methionine, sulfonates and sulfonate esters. Many organisms have evolved 
pathways to obtain sulfite (19) from organosulfur molecules available in nature like 
taurine (16), alkanesulfonates (20) and dibenzothiophene (22, Figure 2.1). These 
pathways are typically upregulated to acquire sulfur from the environment under limiting 
sulfur conditions. The tau operon encodes taurine dioxygenases (TauD) that catalyzes 
oxygenation of taurine,28 the ssu operon encodes a flavin monooxygenase SsuD that acts 
on alkanesulfonates29 and the dsz operon encodes a flavin dependent DszA and a 
hydrolase DszB that catalyze C-S cleavage during dibenzothiophene catabolism.30 
  8 
 
Figure 2.1: Previously reported pathways in which sulfur is retrieved from the 
organosulfur compounds. A) Taurine (16) degradation pathway. B) Alkanesulfonate (20) 
degradation pathway. C) Dibenzothiophene (22) desulfurization through 4S pathway. 
 
 
 
2.2 Identification of a new pathway involved in S-substituted cysteine (7) 
catabolism14 
The gram-positive bacterium Bacillus subtilis uses diverse sources of sulphur 
available in its environment for survival and growth. Recently, growth studies were 
performed on B.subtilis in absence of an inorganic sulfur source but in presence of S-
alkylated cysteines shown in Figure 2.2A. Slow growth of bacteria was observed on 
these organosulfur compounds. This indicates that the bacteria are able to retrieve sulfur 
from these compounds and there is a novel pathway involved in this transformation. 
Transcriptome profiling was performed using DNA microarrays to identify the mRNA 
transcripts that were upregulated in presence of these organosulfur compounds. One of 
the operons which was upregulated is operon ytmI_tcyJKLMNytmO_ytnJ_rbfK_ytnLM 
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(now renamed snaAtcyJKLMNcmoO_cmoIJ_rbfK_sndAytnM) as shown in Figure 2.2B. 
The putative function of genes in this operon is provided in Table 1.14 
 
 
 
 
 
Figure 2.2: Identification of the cysteine salvage pathway. A) S-substituted cysteines 
used as sulfur source for growth studies in B.subtilis. B) Operon that is upregulated 
when organosulfur compounds are used as a sole source of sulfur in media. 
 
 
 
Table 2.1: Functional annotation of genes involved in cysteine salvage pathway. 
Sr. no. Gene Renamed Proposed Function 
1 ytmI snaA Acetyl transferase 
2 ytmJ tcyJ Periplasmic binding protein 
3 ytmK tcyK Periplasmic binding protein 
4 ytmL tcyL Amino acid ABC-transporter protein 
5 ytmM tcyM Amino acid ABC-transporter protein 
6 ytmN tcyN Amino acid ABC-transporter protein 
7 ytmO cmoO Flavin dependent monooxygenase 
8 ytnI cmoI Glutaredoxin 
9 ytnJ cmoJ Flavin dependent monooxygenase 
10 rbfK ribR Riboflavin kinase 
11 ytnL sndA Deacetylase / Amidohydrolase 
12 ytnM ytnM Transmembrane protein 
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 The relevance of the genes from this operon in utilizing organosulfur compounds 
was confirmed by gene deletion studies. Further in vivo studies demonstrated that the 
genes involved in cysteine biosynthesis are not expressed when B.subtilis is grown in 
presence of the organosulfur compounds. This suggested that L-cysteine is salvaged by 
this pathway instead of obtaining sulfur in the form of sulfite. A model outlining roles of 
all enzymes in the pathway was proposed as shown in Figure 2.3.14 
 
 
 
 
Figure 2.3: Proposed role of each enzyme in the cysteine salvage pathway. 
 
 
 
 According to the proposal, the pathway is upregulated in absence of direct sulfur 
sources. The amino acid binding proteins and the periplasmic binding proteins transport 
organosulfur molecules available in the environment into the bacteria. The S-substituted 
cysteines (7) are then acetylated by SnaA (acetyl transferase) to N-acetyl-S-substituted 
cysteines (29). Action of CmoJ (flavin monooxygenase) and CmoI (glutaredoxin) leads 
to the formation of hydroxylated compound 30. This compound is further oxidized to the 
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corresponding ketone 31 by CmoO (flavin monooxygenase). SndA (amidohydrolase) 
deacetylates the ketone 31, which results in the formation of a free amino group. This 
intermediate undergoes S-N formyl shift to generate compound 32, which can be 
deformylated by DefB (deformylase present in B.subtilis) or deacetylated using SndA 
(amidohydrolase) to generate L-cysteine (8).  
 
2.3 Results and discussion 
2.3.1 Characterization of SnaA (acetyl transferase) 
 To establish the roles of individual enzymes, we initially focused our attention on 
SnaA (acetyl transferase) and SndA (amidohydrolase). The activity of purified SnaA 
was investigated with S-methyl-L-cysteine (26), S-carboxymethyl-L-cysteine (28) and L-
methionine (5) in presence of acetyl-CoA (33). As shown in Figure 2.4, the assay 
mixture included Ellman’s reagent (35), which derivatizes the thiol group of coenzyme 
A (34) and liberates 5-thio-2-nitrobenzoate (37) with λmax =412 nm.31  
 
 
 
 
Figure 2.4: Investigating the acetyl transferase activity. A) Transfer of acetyl group to 
the substrate in presence of SnaA will generate coenzyme A (34). B) Derivatization of 
coenzyme A (34) with Ellmans’s reagent (35) generates chromophore (37). 
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 The enzymatic activity was monitored on UV-Vis spectrophotometer at 412 nm. 
As shown in Figure 2.5, amongst the substrates mentioned above, highest activity was 
observed with S-methyl-L-cysteine (26). The activity of SnaA with L-methionine (5) as 
well as other canonical amino acids was low, which suggests that the enzyme prefers S-
substituted cysteines (7) as substrates over other amino acids present in vivo.  
 
 
 
 
Figure 2.5: Monitoring formation of 5-thio-2-nitrobenzoate (37) at 412 nm during SnaA 
catalyzed reaction. 
 
 
 
 
2.3.2 Characterization of SndA (amidohydrolase) 
 His-tagged SndA was found to be insoluble during purification since it formed 
inclusion bodies. The soluble form of the enzyme was obtained by co-expressing it with 
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tig-chaperone in E.coli BL21(DE3) strain.32 The deacetylase activity was not observed 
when the enzyme was pre-treated with 8-hydroxy-5-quinolinesulfonic acid to chelate 
divalent metal ions present during enzymatic reaction.33 However, the activity was 
restored by addition of Zn+2 or Co+2 with substrates like N-acetyl-S-methyl-L-cysteine as 
well as with N-acetyl-L-cysteine. This suggests that deacetylation might occur during 
one of the intermediate steps or at the final step in this pathway. The activity was 
confirmed using LC-MS by derivatizing the free thiol with bromobimane (40).34 
 
 
 
 
 
Figure 2.6: Analysis of SndA catalyzed deacetylation. A) Scheme showing reaction 
catalyzed by SndA. B) Derivatization of L-cysteine (8) with bromobimane (40). C) LC-
MS analysis showing EIC [M-H]- = 310 Da demonstrating formation of 8 in presence of 
SndA and Co+2, which is further derivatized with 40. D) MS of reaction product 41 in 
negative mode. 
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Figure 2.6 Continued 
 
 
 
2.3.3 Sulfoxidation catalyzed by CmoO (flavin monooxygenase) 
 Next, the activity of CmoO, CmoI and CmoJ was investigated with N-acetyl-S-
methyl-L-cysteine (42) as substrate using 1H-NMR. The enzymes were tested 
individually as well as in different combinations. In presence of CmoO, a new signal was 
obtained at 2.7 ppm after ~18 hr. The enzyme utilizes FMN as a cofactor and NADH 
was added in enzymatic reaction to generate FMNH2. However, bioinformatic analysis 
and UV-Vis analysis at 340 nm investigating NADH consumption suggested that CmoO 
lacks flavin reductase activity. To have a continuous supply of FMNH2, flavin reductase 
(Fre) from E.coli was included during the CmoO catalyzed reaction.35 As shown in 
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Figure 2.7, within few a minutes disappearance of a signal at 2.1 ppm concomitant with 
formation of new signals at 2.7 ppm and 3.3 ppm were observed.  
 
 
 
 
Figure 2.7: 1H-NMR analysis of the CmoO catalyzed reaction with N-acetyl-S-methyl-
L-cysteine (42) in presence of Fre, FMN and NADH. In ‘Full reaction’ sample formation 
of new signals was observed at 2.7 ppm and 3.3 ppm in concert with disappearance of 
signal at 2.1 ppm. 
 
 
 
The downfield shift of protons adjacent to sulfur in N-acetyl-S-methyl-L-cysteine 
(42) suggests that the CmoO has an oxidized sulfur atom. The identity of this product 
was confirmed to be N-acetyl-S-methyl-L-cysteine sulfoxide (43) by spiking enzymatic 
reaction with the synthesized standard. The synthetic standard of 43 consists of the two 
diastereomers of the molecule. As shown in Figure 2.8, 1H-NMR analysis at 2.7 ppm 
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showed that the methyl proton of 43 generated enzymatically corresponds to the methyl 
protons from one of the diastereomers of 43.  
 
 
 
 
 
Figure 2.8: Identifying the product generated by CmoO catalyzed reaction. A) Scheme 
for synthesizing authentic standard of 43. B) Diastereomers of 43. C) 1H-NMR analysis 
of the synthetic standard shows a doublet at 2.7 ppm (blue trace). When the CmoO ‘Full 
Reaction’ sample is spiked with 43, it matches with the upfield proton signal at 2.7 ppm. 
 
 
N
H
S
O
O OH
N
H
S
O O
O OH
H2N
S
O OH
O
O O
CH3COOH, 60°C
H2O2
CH3COOH, 25°C
N
H
S
O O
O OH
N
H
S
O O
O OH
N
H
S
O
O OH
O
(R)sulfoxide (S)sulfoxide
A)
B)
4226 43
43 43a 43b
C) 
CmoO Full reaction spiked with standard of 43 
Synthetic standard of 43 
  17 
2.3.4 Determining the stereochemistry of sulfoxide generated by CmoO 
To determine the stereochemistry of 43 generated during the CmoO catalyzed 
reaction, we inspected enzymes reported in literature that consume stereospecific 
sulfoxide substrates. Methionine sulfoxide reductases (Msr) are ubiquitously found in 
many organisms and are involved in repairing oxidative damage to L-methionine (5) 
residue in proteins. MsrA stereospecifically reduces the S-sulfoxide while MsrB reduces 
the R-sulfoxide stereoisomer.36 These enzymes show broad substrate specificity and 
have been previously shown to reduce N-acetyl-S-methyl-L-cysteine sulfoxide (43). As 
shown in Figure 2.9, activity of MsrA affects the downfield signal at 2.7 ppm 
corresponding to the methyl protons of 43. This demonstrates that the downfield signal 
belongs to the S-sulfoxide and upfield signal belongs to the R-sulfoxide stereoisomer. 
 
 
 
 
Figure 2.9: Identifying stereoisomers of N-acetyl-S-methyl-L-cysteine sulfoxide (43). 
Analysis of 1H-NMR shows a doublet at 2.7 ppm. When MsrA is added, the downfield 
signal is consumed which demonstrates that it corresponds to S-stereoisomer of 43. 
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In Figure 2.8C, it can be seen that the stereospecific sulfoxide generated from the 
CmoO catalyzed corresponds to the upfield signal at 2.7 ppm of 43. By utilizing MsrA, 
as shown in Figure 2.9, the downfield signal at 2.7 ppm was assigned to the S-
stereoisomer whereas the upfield signal corresponds to the R-stereoisomer of 43. This 
demonstrates that in the CmoO catalyzed reaction generates the R-stereoisomer of 43. 
Additionally, no activity of CmoO was observed with S-methyl-L-cysteine (26) while 
SndA was also unable to deacetylate N-acetyl-S-methyl-L-cysteine-R-sulfoxide (43a). 
Based on the reconstitution and preliminary studies of the above-mentioned three 
enzymes in this pathway, a revised model was proposed as shown in Figure 2.10. 
 
 
 
 
Figure 2.10: Revised model outlining the role of enzymes involved in the cysteine 
salvage pathway. 
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2.3.5 Pummerer type rearrangement catalyzed by CmoJ (flavin monooxygenase) 
 A key question that emerged after reconstitution of CmoO was how a flavin 
monooxygenase (CmoJ) and glutaredoxin (CmoI) are involved in catalyzing formation 
of a thiol (38) from a sulfoxide (43a) in this pathway. The product 43a of CmoO was 
tested as a substrate for CmoJ (flavin monooxygenase) and CmoI (glutaredoxin). Despite 
several attempts of varying in vitro enzymatic reaction conditions and performing 
coupled assays, 1H-NMR analysis did not show consumption of signals corresponding to 
43 or appearance of any new signal. With an aim of developing a sensitive assay in 
which substrate consumption can be monitored using HPLC, I surveyed literature for 
additional S-substituted cysteines (7) that include a chromophore. Molecules like S-
benzyl-L-cysteine (44) and its sulfoxide, which are observed in roots of some plants, 
have been previously reported.37 N-acetyl-S-benzyl-L-cysteine sulfoxide (46) was 
synthesized and tested as a substrate for CmoJ. As shown in Figure 2.11, HPLC analysis 
showed the consumption of one stereoisomer within few minutes. 
 
 
 
 
Figure 2.11: Investigating N-acetyl-S-benzyl-L-cysteine sulfoxide (46) as a substrate for 
the CmoJ catalyzed reaction. A) Scheme depicting synthesis of 46. B) HPLC analysis of 
the CmoJ catalyzed reaction with 46 (diastereomers) at 220 nm in presence of Fre, FMN 
and NADH. Consumption of one stereoisomer at 12.5 min was observed in the ‘Full 
reaction’ sample. 
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Figure 2.11 continued. 
 
 
 
The activity of the CmoJ catalyzed reaction with 46 was quite robust. Further 1H-
NMR analysis of enzymatic reaction in the downfield region demonstrated formation of 
benzaldehyde as one of the products as shown in Figure 2.12. The other product was 
identified as N-acetyl-L-cysteine (38) only in the presence of reducing agents like TCEP.  
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Figure 2.12: 1H-NMR analysis of the CmoJ catalyzed reaction. The downfield region 
shows formation of new signals in ‘Full reaction’ sample at 9.8 ppm and between 7.5-8.0 
ppm (red trace). NMR of the authentic standard of benzaldehyde confirms that it is one 
of the products of CmoJ catalyzed reaction with 46.  
 
 
 
 
A mechanistic proposal accounting for the formation of benzaldehyde (50) and 
an oxidized cysteine containing compound is shown in Figure 2.13A. N-acetyl-S-benzyl-
L-cysteine sulfoxide (46) is deprotonated at the α-carbon by CmoJ. The resulting 
carbanion 47 attacks C4a-flavinhydroperoxide, which is a common intermediate in flavin 
monooxygenases. This leads to the formation of intermediate 48, which collapses to 
generate benzaldehyde (50) and N-acetyl-L-cysteine sulfenic acid (49). This reaction can 
be classified as Pummerer-type rearrangement. Reduction of sulfonium sulfur 
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concomitant with oxidation or substitution at the α-carbon is referred to as the 
Pummerer rearrangement an example of which is shown in Figure 2.13B.38 
 
 
 
 
Figure 2.13: Mechanistic proposal of the CmoJ catalyzed reaction with N-acetyl-S-
benzyl-L-cysteine sulfoxide (46). A) Proposed products with 46 as substrate are 
benzaldehyde (50) and N-acetyl-L-cysteine sulfenic acid (49). B) An example of 
Pummerer rearrangement. 
 
 
 
Sulfenic acids are highly reactive species, which can function either as a weak 
nucleophile or soft electrophile.39 In absence of any reducing agents, they undergo self-
condensation to form thiosulfinates, while they are reduced to thiol in presence of a 
reducing agent. To investigate the formation of a sulfenic acid 49, the CmoJ catalyzed 
reaction was performed in presence of dimedone (56).40 As shown in Figure 2.14, the 
adduct 57 was detected using LC-MS. To further confirm formation of the sulfenic acid, 
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the enzymatic reaction was performed in presence of 4-mercaptopyridine (58), which 
derivatizes sulfenic acid 49 and its dimer thiosulfinate 55.41 The adduct 59 was 
established using LC-MS and was further characterized by co-injection with synthetic 
standard using HPLC and followed by NMR. When the enzymatic reaction was 
performed in presence of reducing agent like TCEP, formation of N-acetyl-L-cysteine 
(38) was observed in 1H-NMR. This was further confirmed by the derivatization of N-
acetyl-L-cysteine (38) with NBD-Cl (60) and analyzing with HPLC and LC-MS the 
formation of adduct 61. 
 
 
 
 
Figure 2.14: Evidence for the formation of sulfenic acid during the CmoJ catalyzed 
reaction. A) Scheme showing various derivatization reagents used to derivatize sulfenic 
acid 49. B) LC-MS analysis showing EIC [M-H]- = 300 Da demonstrating formation of 
57 in presence of dimedone (56). The inset shows MS of the reaction product 57 in 
negative mode. C) LC-MS analysis showing EIC [M-H]- = 271 Da demonstrating 
formation of 59 in presence of 4-mercaptopyridine (58). The inset shows MS of the 
reaction product 59 in negative mode. D) HPLC analysis of the reaction mixture treated 
with 58 at 254 nm showing coinjection with the authentic standard of 59. E) 1H-NMR 
and 13C-NMR of the adduct 59. F) HPLC analysis of the CmoJ reaction treated with 
NBD-Cl (60) at 425 nm confirming formation of 61 only in presence of reducing agents 
like TCEP. G) MS of the adduct 61. 
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Figure 2.14 continued. 
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To further investigate mechanistic proposal outlined in Figure 2.13A, the 
incorporation of O2 in products can be studied. If enzymatic reaction is performed in 
presence of 18O2, an increase of 2 Da should be observed in benzaldehyde. To decrease 
the rate of oxygen exchange of benzaldehyde in aqueous environment, an electron-
donating group can be added at ortho or para positions of the benzene ring.42 Thus, N-
acetyl-S-(p-hydroxybenzyl)-L-cysteine sulfoxide (62) was synthesized and was found to 
be a good substrate of CmoJ. The enzymatic reaction was performed in presence of 16O2 
and 18O2, and was quenched after 10 minutes using ethyl acetate to prevent further 
exchange of oxygen. The organic layer was treated with BSTFA to derivatize the 
hydroxyl group of 63 and the sample was analyzed using GC-MS.43 Increase in mass by 
2 Da was observed in the trimethylsilyl derivative of p-hydroxybenzaldehyde 64 when 
the reaction was performed in 18O2 confirming it is the source of oxygen in the product. 
 
 
 
 
Figure 2.15: Incorporation of O2 into product during the CmoJ catalyzed reaction. A) 
Reaction of CmoJ with 62 generates p-hydroxybenzaldehyde (63) which is treated with 
BSTFA to form 64. B) GC-MS of the product when the reaction is performed in presence 
of 16O2 shows mass = 194 Da. B) GC-MS of the product when the reaction is performed 
in presence of 18O2 shows increase in the mass of product by 2 units to 196 Da. 
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Figure 2.15 continued. 
 
 
 
 To investigate the substrate tolerance of CmoJ and gain further insights into its 
substrate specificity, we synthesized variants of S-substituted cysteine (7). These analogs 
were fed to CmoJ in presence of Fre, FMN, NADH and 4-mercaptopyridine (58). The 
formation of adduct 59 was analyzed on HPLC at 254 nm and quantified by generating a 
calibration curve from the synthesized standard of 59. Michaelis-Menten kinetic plots 
were laid out for these analogs and the kcat, Km values were obtained (Figure 2.16).  
 
 
 
 
Figure 2.16: Michaelis-Menten kinetic plots of the CmoJ catalyzed reaction with the 
respective substrate analogs. 
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Figure 2.16 continued. 
 
 
 
Table 2.2: Summary of kcat and Km values of various analogs tested with CmoJ. 
Sr. 
# 
 
Substrate analog 
kcat 
(s-1) 
Km 
(µM) 
kcat/ Km 
(M-1 s-1) 
1. N-Acetyl-S-methylcysteine sulfoxide 
(43) 
0.18 + 0.01 322 + 26 5.58 x 102 
2. N-Acetyl-S-carboxymethylcysteine 
sulfoxide (65) 
1.71 + 0.03 114 + 7 1.49 x 104 
3. N-Acetyl-S-benzylcysteine sulfoxide 
(46) 
2.66 + 0.12 7.1 + 1 3.72 x 105 
4. N-Acetyl-S-(p-hydroxybenzyl)cysteine 
sulfoxide (62) 
1.92 + 0.11 6.4 + 1 3.63 x 105 
5. N-Acetyl-S-(p-methoxybenzyl)cysteine 
sulfoxide (66) 
1.73 + 0.05 4.76 + 0.5 3.0 x 105 
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As shown in Table 2.2, N-acetyl-S-methyl-L-cysteine sulfoxide (43) is a poor 
substrate for CmoJ followed by N-acetyl-S-carboxymethyl-L-cysteine sulfoxide (65), 
while N-acetyl-S-benzyl-L-cysteine sulfoxide (46) was the best substrate amongst all 
compounds tested. This is coincident with the trend of pKa value of the proton attached 
to the α-carbon of sulfoxide (deprotonation is the first step in the mechanistic proposal 
outlined in Figure 2.13A). This also suggests that N-acetyl-S-benzyl-L-cysteine 
sulfoxide (46) might be the native substrate of CmoJ.  
 
2.3.6 Crystal structure of the flavin monooxygenase CmoJ 
 To gain further insights into the substrate specificity of CmoJ, we turned our 
attention to the active site architecture of CmoJ and decided to obtain crystal structure of 
the enzyme. Researchers from the structural genomics consortium have previously 
deposited the structures of the apo enzyme (PDB id: 1TVL, 2.1 Å) and the FMN bound 
(PDB id: 1YW1, 2.81 Å) enzyme. However, both the structures have more than 35 
amino acid residues (Arg 304 – Glu 341) missing near the FMN binding site and do not 
offer any information on the residues involved in binding substrate. We obtained the 
crystals of CmoJ in its apo form (1.69 Å) and also bound with FMN (1.90 Å). As shown 
in Figure 2.17, the core of the enzyme has a classic TIM barrel fold consisting the (αβ)8 
strands with additional α-helices forming the lid domain (missing in previous structures). 
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Figure 2.17: Crystal structure of CmoJ. A) Snapshot of the crystals of CmoJ viewed 
under microscope. B) Crystal structure in the Apo form. C) Crystal structure of the FMN 
bound CmoJ. A huge empty pocket above FMN can be observed. 
 
 
 
 
 
 
A) 
B) C) 
  30 
Table 2.3: Data collection and refinement statistics for CmoJ. 
 CmoJ (Apo form) CmoJ + FMN + LFN 
Data collection   
Space group P 43 21 2 P 43 21 2 
Cell dimensions     
    a, b, c (Å) 86.75, 86.75, 195.42 87.07, 87.07, 194.94 
    α, β, γ (°)  90, 90, 90 90, 90, 90 
Resolution (Å) 61.34-1.69 
(1.74-1.69) * 
38.94-1.90 
(1.97-1.90) 
Rmerge 0.14 (1.884) 0.140 (1.029) 
I / σI 12.1 (1.4) 16.14 (1) 
Completeness (%) 100 (100) 100 (99.3) 
Redundancy 21.2 (23.4) 6.8 (5.4) 
   
Refinement   
Resolution (Å) 1.69 1.90 
No. reflections 84371 59542 
Rwork / Rfree 0.174/0.190 0.171/0.201 
No. atoms   
    Protein 3420 3407 
    Ligand/ion NA 50 
    Water 296 216 
B-factors   
    Protein 37.38 54.23 
    Ligand/ion NA 75.47 
    Water 41.42 49.62 
R.m.s. deviations   
    Bond lengths (Å) 0.006 0.010 
    Bond angles (°) 0.750 0.952 
*Values in parentheses are for highest-resolution shell. 
 
 
 
Despite several co-crystallization and soaking experiments with substrate analogs 
mentioned in Table 2.2, we were unable to obtain a substrate bound structure of the 
enzyme. We propose that the substrate-binding site is located in the huge empty pocket 
above FMN. Also, substrate binding may involve conformational changes such that the 
residues on the top domain will close above FMN and substrate during catalysis. We 
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have recently observed such movement of a lid domain after binding of the substrate 
with riboflavin lyase (RcaE), which is discussed in the next section. 
 
2.3.7 Reduction of sulfenic acid with CmoI (glutaredoxin) 
 Sulfenic acid 49 was demonstrated to be the product of CmoJ catalyzed reaction 
using several derivatization strategies. To prevent any damage due to the reactive nature 
of the sulfenic acid, this pathway encodes a glutaredoxin enzyme CmoI that might play a 
role in reduction of 49 to N-acetyl-L-cysteine (38).44 As shown in Figure 2.18, the 
activity of CmoI was demonstrated by performing a coupled enzymatic reaction with 
CmoJ and derivatization of the product 38 using NBD-Cl (60).45 
 
 
 
 
Figure 2.18: CmoI catalyzed reduction of sulfenic acid. A) The active site disulfide of 
CmoI can be reduced with a reductase in vivo. The reduced thiol will attack the sulfenic 
acid and form a crosslink. A second thiol in the active site can attack the disulfide to 
liberate the small molecule. B) CmoI catalyzed reduction of 49 during coupled reaction 
with CmoJ. Product 38 was derivatized with 60 which was confirmed by LC-MS. C) 
LC-MS analysis showing EIC [M-H]- = 325 Da demonstrating formation of 61 during 
CmoI-CmoJ coupled reaction. The inset shows MS of the derivatized reaction product 
61 in negative mode. 
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Figure 2.18 continued. 
 
 
 
2.4 Conclusion 
 We have demonstrated the roles of all enzymes involved in this recently 
discovered L-cysteine (8) salvage pathway. Mechanistic insights were obtained for key 
reactions. As shown in Figure 2.19, acetylation by SnaA during the first step channels 
the right substrate to the rest of the pathway. Additionally, it may also prevent the toxic 
effects due to similarity of these non-canonical amino acids to L-cysteine (8) and L-
methionine (5). Compound 29 is further oxidized to a stereospecific sulfoxide 67 by the 
flavin-monooxygenase CmoO. The second flavin-monooxygenase CmoJ, catalyzes the 
Pummerer-type rearrangement and generates sulfenic acid 49. The highly reactive 49 is 
further reduced by CmoI and is deacetylated in the final step by SndA generating L-
cysteine (8).  
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Figure 2.19: Role of the enzymes involved in cysteine salvage pathway. A) Substrates 
and products of enzymes in the pathway. B) Gene cluster involved in cysteine salvage 
pathway (enzymes are color coded as green). 
 
 
 
Kinetic studies using various substrate analogs for the CmoJ catalyzed reaction 
showed enhanced activity with S-benzyl substituted cysteine. S-benzyl-L-cysteine was 
also found to be an efficient substrate for the SnaA catalyzed acetylation followed by the 
CmoO catalyzed sulfoxidation. This suggests that the S-benzyl substituted cysteines are 
preferred substrates of the enzymes in this pathway. Since this pathway is involved in 
salvage of L-cysteine (8) it is interesting to note that both the flavoenzymes CmoO and 
CmoJ do not contain any cysteine residues. 
Previous studies on C-S lyases have predominantly focused on PLP dependent 
enzymes like alliinase46 and EgtE in Ergothionine biosynthesis.47 In Figure 2.1C we saw 
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examples of flavin mediated C-S lyases like the DszA involved in dibenzothiophene 
catabolism48 and SsuD involved in alkanesulfonate metabolism.49 Other reported 
examples include prenylcysteine lyase which is an FAD oxidase and doesn’t generate 
sulfoxide nor requires NAD(P)H for its activity.50 This study expands the repertoire of 
enzymes from flavin superfamily, which can catalyze C-S lyase activity by modulating 
the accessible redox states of sulfur. 
The cysteine salvage pathway sheds light on a survival strategy evolved by 
microbes to obtain sulfur from organosulfur molecules produced by plants. 
Bioinformatic analysis has shown that this pathway is found in organisms that are 
closely associated with the roots of plants.14 The pathway is upregulated in absence of 
readily available sulfur sources in the environment. The transporter and periplasmic 
proteins in the operon, play a role in the intake of S-substituted cysteines (7).51 Recently, 
RibR was characterized as a dual functional enzyme demonstrating riboflavin kinase 
activity and regulating biosynthesis of flavins by binding FMN riboswitches.52 This 
pathway uses various S-substituted cysteines (7) available in the environment as 
substrates and generates L-cysteine (8), which serves as a source of sulfur for any sulfur 
containing metabolite in those bacteria.  
 
2.5 Experimental procedures 
Materials: All chemicals were purchased from Sigma-Aldrich (now 
MilliporeSigma) unless specified otherwise. LB broth (Lennox formulation) was from 
EMD Millipore. Kanamycin was from Teknova and IPTG was obtained from Lab 
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scientific Inc. Chloramphenicol was from Fisher Scientific. HPLC and LC-MS solvents 
were purchased from EMD and were used without further purification. Histrap column 
(5 ml) was obtained from GE healthcare. Econo-Pack 10DG and Bio-spin 6 desalting 
columns were purchased from Bio-Rad Laboratories. Large cultures were grown and 
overexpressed in 2.5 L baffled ultra yield flasks from Thomson Instrument Company. 
NMR tubes with diameter of 3 mm and 5 mm were obtained from Wilmad-Labglass. 
D2O, MeOD and d6-DMSO were purchased from Cambridge Isotope Laboratories Inc. 
MsrA was gene synthesized and cloned in pTHT vector [modified pET28b with TEV 
protease cleavage site after N-terminal His-tag] by GenScript. 
 
Overexpression and purification of enzymes: Genes of snaA, cmoO, cmoI, cmoJ 
and sndA were cloned in pTHT vector (derivative of pET28b vector with TEV protease 
cleavage site after N-terminal His-tag) while TEV protease was cloned in pET28b 
vector. The respective plasmids were transformed into BL21(DE3) competent cells of 
E.coli using electroporation technique. Starter cultures were grown overnight in LB 
media containing kanamycin (40 μg/ml). 30 ml of this culture was added to 3L LB 
media (2 x 1.5L flasks) with antibiotics and grown at 37 °C with shaking (180 rpm) till 
OD600~0.6.  The flasks were then incubated at 4 °C for ~2 hr without shaking. Cultures 
were then induced with 500 μM IPTG followed by incubation at 15 °C for ~14 hr with 
shaking at 180 rpm. The cells were harvested by centrifugation at 5,000 rpm for 20 min 
and stored in liquid nitrogen until further use. Typical yields were 9-10 gm of cell pellet 
(wet weight) from 3L cell culture.  
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For purification, the cell pellets were thawed and resuspended in 40-50 ml of 
lysis buffer (100 mM KPi, 150 mM NaCl, pH 7.5) at room temperature in the presence 
of lysozyme (6-8 mg). The suspension was stirred for ~1.5 hr on an ice-bath and further 
sonicated to lyse the cells. Cell debris was removed by centrifugation at 15,000 rpm for 
20min and the lysate was filtered using 0.22 µm filters. The filtered lysate was loaded 
onto a His-trap column pre-equilibrated with lysis buffer. The column was washed with 
10 column volumes of wash buffer (100 mM KPi, 20 mM imidazole, 150 mM NaCl, pH 
7.5). The protein was then eluted from the his-trap column with elution buffer (100 mM 
KPi, 250 mM imidazole, 150 mM NaCl, pH 7.5). Protein containing fractions which 
were identified using Bradford reagent, were pooled together and concentrated using 15 
ml 10kda filters. The concentrated protein was buffer exchanged to 50 mM KPi, 10% 
glycerol, pH 7.5 using the Econo-Pac 10DG desalting column. Aliquots of 100 µl 
desalted enzyme in eppendorf tubes were flash frozen in liquid nitrogen and stored in -
80 °C until further use. Protein concentration was determined by measuring the 
absorbance at 280 nm (A280) and utilizing the extinction coefficient calculated using 
ProtParam tool of the ExPASy proteomics server.  
 
Co-expression of sndA with tig chaperone: Plasmid pTF16 encoding tig 
chaperone was obtained commercially (TaKaRa Bio Inc. chaperone plasmid set).53 
Competent cells of BL21(DE3) were transformed with pTF16 followed by plasmid 
containing sndA. Starter cultures were grown overnight in LB media containing 
kanamycin (40 μg/ml)	 and	 chloramphenicol	 (25	 μg/ml). 30 ml of this culture was 
added to 3L LB media (2 x 1.5L flasks) containing 3 mg/ml L-arabinose and antibiotics. 
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The flasks were grown at 37 °C with shaking (180 rpm) till OD600 ~0.6 and further 
incubated at 4 °C for ~2 hr without shaking. Cultures were then induced with 500 μM 
IPTG followed by incubation at 15 °C for ~14 hr with shaking at 180 rpm. The cells 
were harvested by centrifugation at 5,000 rpm for 20 min and stored in liquid nitrogen 
until further use. Purification of enzyme using His-tag column was performed using the 
procedure mentioned in the previous page. 
 
Purification of CmoJ for crystallographic studies: The cells were overexpressed 
and purified as described in the previous page. However, Tris buffer was used instead of 
KPi buffer throughout purification. After desalting CmoJ, purified TEV protease was 
added to it in the ratio TEV:CmoJ = 1:10 and incubated at 30 °C for 4 hr. The solution of 
proteins was passed through Ni-NTA column, which was pre equilibrated with (100 mM 
Tris, 150 mM NaCl, pH 7.5). Histag cleaved CmoJ was eluted from the column using 
100 mM Tris, 20 mM imidazole, 150 mM NaCl, pH 7.5 and further desalted into 10 mM 
Tris, pH 7.5 buffer. The enzyme was either used directly for setting up crystallization 
trials or stored in 100 μl aliquots at -80 °C and used later.  
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Figure 2.20: SDS-PAGE gel of purified proteins. A) Gel showing ladder (from Bio-rad), 
CmoI (10.5 kda), CmoJ (50 kda) and CmoO (37 kda) respectively. B) Time-course 
showing His-tag cleavage of CmoJ using TEV-protease (used for crystallographic 
study). His-tag is completely cleaved after ~4 hr. 
 
 
 
 
HPLC parameters: An Agilent 1200 or 1260 HPLC equipped with a quaternary 
pump was used. The system included a diode array UV-Vis detector and chromatograms 
were detected using absorbance at 220 nm, 254 nm, 260 nm, 280 nm, 340 nm and 425 
nm. Analysis was performed using either SUPELCOSIL LC-18-T (15 cm x 4.6 mm, 3 μm particles, Sigma) or ZORBAX Eclipse XDB-C18 column (15 cm x 4.6 mm, 5 μm 
particles, Agilent Technologies). Data was processed using ChemStation ver. B.04.01 
SP1 (Agilent technologies). 
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HPLC conditions: 
A- Water 
B- 100 mM Potassium phosphate buffer, pH 6.6 
C- Methanol 
 
HPLC method: (Flow rate = 1 ml/min) 
0 min – 100% B, 2 min – 10% A 90% B, 10 min – 45% A 15% B 40% C, 18 min – 25% 
A 15% B 60% C, 20 min - 25% A 15% B 60% C, 22 min - 100% B, 25 min - 100% B. 
 
LC-MS parameters: LC-ESI-TOF-MS was performed using an Agilent 1260 
HPLC system equipped with a binary pump and a 1200 series diode array detector 
followed by a MicroToF-Q II mass spectrometer (Bruker Daltonics) using an ESI source 
in negative mode. Analysis was performed on a LC-18-T column (15 cm x 3 mm, 3	μm 
particles, Supelco). Data was processed using DataAnalysis 4.0 SP1 (Bruker Daltonics). 
 
LC conditions:  
A- 5 mM Ammonium acetate buffer, pH 6.6 
B- 75% Methanol and 25% Water. 
 
LC method: (Flow rate = 0.4 ml/min) 
0 min – 100% A, 7 min – 100% A, 10 min – 80% A 20% B, 27 min – 100% B, 29 min – 
100% B, 30 min – 100% A, 40 min – 100% A. 
 
Reconstitution of SnaA catalyzed acetyl transferase: A reaction mixture (1 ml) 
consisting of 1 µM SnaA, 500 µM acetyl CoA (33), 500 µM DTNB (35, 100 mM stock 
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in DMSO) in 50 mM KPi buffer, pH 7.5 at 25 °C was added in a quartz cuvette. This 
mixture was used as a blank for UV-Vis spectrophotometer. The reaction was initiated 
by adding substrate/analog and the Absorbance was recorded at 412 nm for 10 min. 
 
Reconstitution of SndA catalyzed deacetylation: A 100 µl aliquot of 75 µM 
purified SndA was incubated with 1.5 mM 8-hydroxy-5-quinolinesulfonic acid (divalent 
metal chelator) for few hrs. Protein was desalted using Bio-spin 6 desalting columns and 
enzymatic reaction was setup with various metals like Zn+2, Mg+2, Fe+2, Fe+3, Ni+2, 
Mn+2, Co+2. A reaction mixture (100 µl) consisting of 10 µM SndA, 1 mM N-acetyl-L-
cysteine (38), 1 mM TCEP, 1 mM metal solution in 50 mM KPi buffer, pH 7.5 at 25 °C 
was incubated for 2 hr. Protein was removed from sample using a 10 kda filter. A 50 
mM Bromobimane (40) solution in DMSO was prepared and 4 µl was added to each 
sample. Samples were analyzed on LC-MS by injecting 80 µl of the reaction mixture.  
 
Reconstitution of CmoO catalyzed sulfoxidation: Samples for NMR analysis 
were prepared by separately desalting Flavin reductase (Fre) and CmoO using Bio-spin 6 
desalting columns to remove glycerol from protein solution. A reaction mixture (400 µl) 
consisting of 1 µM Fre, 40 µM CmoO, 250 µM FMN, 10 mM NADH, 5 mM N-acetyl-
S-methyl-L-cysteine (38) in 50 mM KPi buffer, pH 7.5 at 25 °C was incubated for 30 
min. 100 µl of D2O-KPi buffer, pD 7.1 was added to enzymatic reaction and the samples 
were transferred to NMR tubes. NMR was recorded using Bruker Avance III 400 MHz 
instrument. To identify the stereoisomer generated during CmoO catalyzed reaction, the 
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‘Full reaction’ sample was spiked with synthetic diastereomers of N-acetyl-S-methyl-L-
cysteine sulfoxide (43) and NMR was recorded. 
 Samples prepared for HPLC / LC-MS analysis had the following composition. A 
reaction mixture (100 µl) consisting of 150 nM Fre, 10 µM CmoO, 25 µM FMN, 1 mM 
NADH, 500 µM N-acetyl-S-benzyl-L-cysteine in 50 mM KPi buffer, pH 7.5 at 25 °C 
was incubated for 30 min. Protein was removed using 10 kda filter and 40-80 µl of 
sample was injected in HPLC / LC-MS.  
 
Determining stereochemistry of sulfoxide by MsrA: Samples for NMR analysis 
were prepared by desalting MsrA using Bio-spin 6 desalting columns to remove 
glycerol. NMR was recorded of 100 µl of D2O-KPi buffer added to a reaction mixture 
(450 µl) consisting of 20 µM MsrA, 3 mM DTT and 10 mM N-acetyl-S-methyl-L-
cysteine sulfoxide (43) in 50mM KPi buffer, pH 7.5 at 25 °C which was incubated for 
30min. Additional 3 mM DTT was added to let the reaction go to completion and NMR 
of the sample was recorded again. 
 
Reconstitution of the flavin monooxygenase CmoJ: Samples for NMR analysis 
were prepared by desalting Flavin reductase (Fre) and CmoJ using Bio-spin 6 desalting 
columns to remove glycerol. A reaction mixture (400 µl) consisting of 1 µM Fre, 40 µM 
CmoJ, 250 µM FMN, 10 mM NADH, 5 mM N-acetyl-S-methyl-L-cysteine sulfoxide 
(43) or N-acetyl-S-benzyl-L-cysteine sulfoxide (46) in 50 mM KPi buffer, pH 7.5 at 25 °C was incubated for 2-18 hr. 100 µl of D2O-KPi buffer, pD 7.1 was added to each 
sample and NMR spectra was recorded. 
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 Identity of benzaldehyde (50) and N-acetyl cysteine (38, after addition of TCEP) 
as products of CmoJ catalyzed reaction was established by recording NMR spectra of the 
product standards individually followed by spiking the ‘Full reaction’ sample with these 
compounds. 
Samples prepared for HPLC / LC-MS analysis had the following composition. A 
reaction mixture (100 µl) consisting of 150 nM Fre, 10 µM CmoJ, 25 µM FMN, 1 mM 
NADH, 500 µM N-acetyl-S-benzyl-L-cysteine sulfoxide (46) in 50 mM KPi buffer, pH 
7.5 at 25 °C was incubated for 30 min. Protein was removed using 10 kda filter and 40-
80 µl of sample was injected in HPLC / LC-MS. Following variations were done to the 
enzymatic reaction set-up to derivatize the sulfenic acid generated during CmoJ 
catalyzed reaction: 2 mM dimedone (56) was included at the start of the reaction to form 
adduct 57, 2 mM 4-mercaptopyridine (58) was included the start of the reaction to form 
adduct 59 while 2 mM TCEP was included at the start of the reaction and 2 mM NBD-Cl 
(60) dissolved in DMSO was added after removing the enzymes using 10 kda filter to 
generate adduct 61.  
For the 18O2 experiment, all buffers and reagents were transferred into the 
anaerobic chamber (< 5 ppm O2, COY Laboratories). Fre and CmoJ were desalted using 
Bio-spin 6 desalting columns into anaerobic buffers. Stock solutions of substrates and 
cofactors were also prepared in anaerobic 50 mM KPi buffer, pH 7.5. A reaction mixture 
(100 µl) consisting of 150 nM Fre, 10 µM CmoJ, 25 µM FMN, 1 mM NADH, 500 µM 
N-acetyl-S-(p-hydroxybenzyl)-L-cysteine sulfoxide (62) were setup in an eppendorf tube 
in two sets and sealed. The eppendorf tubes were removed from anaerobic chamber and 
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exposed with a ballon of 16O2 for one set and 18O2 for the second one. After 10 min, the 
reaction was quenched and extracted with 2 x 100 µl of ethyl acetate. The ethyl acetate 
fraction was concentrated and treated with 2ul of BSTFA to derivatize the hydroxyl 
group of p-hydroxybenzaldehyde (63) at 60 °C for 15min.54 The samples were further 
analyzed using GC-MS. 
 
Synthesis of substrates and products: Synthesis involved formation of S-
substituted-L-cysteine (7), followed by acetylation or sulfoxidation (sequence of 
acetylation and sulfoxidation can be used interchangeably). All steps were performed 
using procedures reported in literature. L-cysteine (8) S-methyl-L-cysteine (26), S-
carboxymethyl-L-cysteine (28) and S-benzyl-L-cysteine (44) were obtained 
commercially from Sigma-Aldrich. The general reaction scheme is shown in Figure 2.21 
and representative 1H-NMR are shown in Figures 2.22 and 2.23.  
Step 1: Preparation of aromatic S-substituted-L-cysteine.55 The reaction was 
setup under Argon atmosphere. In a 25 ml round bottom flask, dissolve 0.2 mmoles of L-
cysteine.HCl in 10 ml of 2N NaOH and add 0.2 mmoles of 4-hydroxybenzyl chloride 
(precursor for 62) or 4-methoxybenzyl chloride (precursor for 66). To this mixture, add 1 
ml of dimethoxyethane. Reaction was allowed to progress for 30 min and was monitored 
using NMR. Once the reaction had gone to completion, the product was extracted using 
ethyl acetate and bulk of the solvent was evaporated using rotovap. Hexane was added 
dropwise to the ethyl acetate fraction to obtain the product as precipitate. The product 
was filtered using Buchner funnel and used for the next step.  
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Step 2: Acetylation of S-substituted-L-cysteine (7).56 In a round bottom flask add 
10 ml acetic acid. Dissolve 0.2 mmoles of a particular S-substituted-L-cysteine (7) and 
add 0.22 mmoles of acetic anhydride. Heat the reaction mixture to 60 °C for 30 min. 
Rotovap the reaction mixture to remove excess acetic acid and acetic anhydride.  
Step 3: Sulfoxidation of the N-acetyl-S-substituted cysteine (29).57 In a round 
bottom flask add 10 ml acetic acid to dissolve 0.2 mmoles of a particular N-acetyl-S-
substituted-L-cysteine (29). Add 100 µl H2O2 solution (33% w/v) and stir at 60 °C for 30 
min. The progress of reaction was monitored using 1H-NMR.  
 
 
 
 
Figure 2.21: Synthetic scheme for substrates and products. 
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Figure 2.22: 1H-NMR spectra of S-methyl-L-cysteine (26), N-acetyl-S-methyl-L-
cysteine (42) and N-acetyl-S-methyl-L-cysteine sulfoxide (43) recorded in D2O. 
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Figure 2.23: 1H-NMR spectra of S-(p-methoxybenzyl)-L-cysteine (26), S-(p-
methoxybenzyl)-L-cysteine sulfoxide (42) and N-acetyl-S-(p-methoxybenzyl)-L-cysteine 
(43) recorded in D2O. 
 
 
 
Synthesis of the adduct 59 between N-acetyl-L-cysteine (38) and 4-
mercaptopyridine: In a round bottom flask, under Argon atmosphere, add 10 ml THF 
(tetrahydrofuran). Dissolve 0.2 mmoles of N-acetyl-L-cysteine (38) and 0.22 mmoles of 
aldrithiol-4 (73) and stir the reaction mixture at 25 °C for 24 hr. Remove the solvent 
using rotovap and dissolve the residue in KPi buffer. Adduct 59 was purified using 
HPLC and was further used to record NMR, co-injection and prepare calibration curve 
for kinetic experiments. 
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Figure 2.24: Synthetic scheme for adduct 59. 
 
 
 
Kinetic studies on CmoJ catalyzed reaction: A reaction mixture (100 µl) 
consisting of 150 nM Fre, 100-2500 nM CmoJ, 20 µM FMN, 1-2000 µM substrate and 1 
mM 4-mercaptopyridine (58) in 50 mM KPi buffer, pH 7.5 at 25 °C was prepared. The 
enzymatic reaction was initiated by addition of 1-2 mM NADH. The reaction was 
quenched at suitable time-points (30-600 sec) using 1:1 ratio of enzymatic reaction and 8 
M guanidine hydrochloride. The enzyme was removed by filtration and analysis of 
samples was performed using HPLC. The amount of adduct 59 was calculated by 
determining the area under the signal at 254 nm. The experiments were performed in 
triplicates for each substrate analog.  
 
Crystal structure of CmoJ: Crystallization trials were setup using commercial 
kits and hanging drop diffusion method. Enzyme concentration was kept close to ~15 
mg/ml. Few hits were obtained at 4 °C and were optimized further optimized to yield 
better quality crystals. 
 
Apo CmoJ: 2.5 µl of reservoir solution was added to 2.5 µl of purified CmoJ on 
the coverslip and sealed on top of a reservoir containing 50 mM HEPES pH 7.5, 200 
THF
~24hrs
N
SH
N
H
SH
O
O OH
38 73
NH
OH
O S
O
S
N
5859
N
S
N
S
  48 
mM KCl and 29%-33% of pentaerythritol propoxylate (5/4 PO/OH) at 4 °C. Diamond 
shaped crystals were obtained after one week which grew larger for ~15 days. 
 
CmoJ with FMN: The apo crystals of CmoJ were soaked overnight in 4 mM 
FMN dissolved in crystallization buffer. 
Glycerol was used as a cryoprotectant while preparing samples for X-ray diffraction. 
 
Collection of X-ray diffraction data: All X-ray diffraction data was collected at 
the Advanced Photon Source (APS), Argonne National laboratory. Crystals of the apo 
CmoJ were diffracted at 100K, at the 23-ID-D beamline using the PILATUS3 6M 
detector and a wavelength of λ= 1.033 Å. Crystals of FMN bound CmoJ were diffracted 
at 100K, at the 19-ID beamline using the DECTRIS PILATUS 2M detector and a 
wavelength of λ= 0.925 Å. Diffraction data was collected for 240-360 frames and was 
recorded in a shutterless mode at the rate of one degree/sec. Datasets were integrated and 
scaled using iMosflm for the apo CmoJ and HKL2000 for the FMN bound CmoJ. 	
Structure determination and refinement: The structure of CmoJ bound with 
FMN was determined by molecular replacement using previously deposited structure of 
the same enzyme PDB id 1YW1 as the starting model. The structures were refined 
iteratively using programs like PHENIX and COOT. The model thus generated was used 
as a starting model for CmoJ (apo form) and CmoJ bound with FMN. The final 
refinement statistics are summarized in Table 2.3. 
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3. STUDIES ON RIBOFLAVIN CATABOLIC PATHWAY AND STRUCTURAL 
ENZYMOLOGY OF RIBOFLAVIN LYASE 
 
3.1 Catabolism of cofactors58 
Genes involved in the biosynthesis of most cofactors were identified in last few 
decades and the mechanistic studies in maximum cases are at advanced stages. These 
studies unraveled a large volume of novel organic chemistry that was unprecedented in 
the biological realm.59 However, despite early reports on the catabolism of several 
cofactors, gene clusters of only heme, pyridoxal phosphate and NAD+ have been 
reported and studied. Bacteria involved in degradation of thiamin, folate, riboflavin and 
biotin were once isolated but have now been lost. The current understanding of cofactor 
catabolism is still in its infancy and has a potential to uncover remarkable series of 
unconventional transformations.  
 
3.2 Gene cluster involved in catabolism of riboflavin (1) 
In 1944, J. W. Foster identified a strain that could degrade riboflavin (1) and 
named the organism Pseudomonas riboflavina (later renamed as Devosia riboflavina 
based on 16S rRNA sequence).15, 60 Further studies with crude cell lysates suggested 
ribitol and lumichrome as products from crude cell extracts. However, the enzymes 
responsible for this transformation remained elusive. In the meantime, additional 
riboflavin degradation pathways were discovered but these strains were lost. In last few 
decades, no progress has been reported on genes and pathways involved in riboflavin 
catabolism. 
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3.2.1 Strain Microbacterium maritypicum G10 catabolizes riboflavin (1) to 
lumichrome (11)19 
 To identify strains that could catabolize riboflavin, dust samples were collected 
from a DSM riboflavin production plant in Switzerland by Dr. Benjamin Philmus 
(former postdoc in Begley lab). These samples were screened in M9 minimal media for 
growth in presence of riboflavin (1) as a sole carbon source. In few samples, bleaching 
of the yellow chromophore of riboflavin was observed. One of the strains that showed a 
robust growth on riboflavin was chosen for further studies. The 16S rRNA sequence 
identified this strain as Microbacterium maritypicum. 
Next, I investigated whether riboflavin could be utilized as a source of carbon as 
well as nitrogen by M. maritypicum. When NH4Cl was excluded from the M9 media 
supplemented with riboflavin, no growth of this strain was observed. This suggested that 
the catabolic pathway is unable to extract the nitrogen’s present in the 3-membered 
isoalloxazine ring of riboflavin and utilize it for growth. As shown in Figure 3.1, further 
experiments on varying riboflavin concentrations in M9 minimal media demonstrated 
that higher concentration of riboflavin in growth media led to higher OD600 values.  
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Figure 3.1: Growth of M. maritypicum in M9 minimal media supplemented with 
riboflavin (1). A) M9 media (no NH4Cl) supplemented with riboflavin, no growth 
observed. B) M9 media (with NH4Cl) supplemented with riboflavin, growth observed. 
C) M9 media + NH4Cl + 3mg riboflavin, bleaching of chromophore and weak growth. 
D) M9 media + NH4Cl + 5mg riboflavin, bleaching of chromophore and robust growth. 
 
 
 
To identify the products generated from degradation of riboflavin (1), the spent 
media was analyzed for metabolites. HPLC analysis of the media showed time-
dependent consumption of 1 and appearance of a new signal, which comigrated with 
lumichrome (11, Figure 3.1A). Analysis of sample after 21 hr showed complete 
consumption of 1, a small peak for 11 and no additional signals were observed on the 
HPLC. This suggested that either lumichrome (11) is completely consumed or it 
precipitates from the growth media. To test for presence of lumichrome, the spent media 
was divided in two fractions. One fraction was filtered (as previously done for HPLC 
samples) while the other was used directly. Both fractions were treated with 1:1 ratio of 
spent media and 1 N KOH solution (KOH increases solubility of lumichrome to 50 
mg/ml).61 UV-Vis spectra of these samples were recorded. As shown in Figure 3.1B, 
lumichrome was observed in sample that was not filtered while the sample which was 
filtered, showed trace amounts of lumichrome (11). Further quantitation of 11 in 
unfiltered sample accounted for ~96% of riboflavin (1) initially added in the media. 
A) B) C) D) 
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Figure 3.2: Degradation of riboflavin (1) to lumichrome (11) by M. maritypicum. A) 
HPLC analysis at 340 nm showing time dependent formation of lumichrome from 
riboflavin. UV-Vis analysis of culture medium treated with 1N KOH after ~30 hr of 
growth. 
 
 
 
3.2.2 Riboflavin catabolic gene cluster in Microbacterium maritypicum G10 
The growth studies of M. maritypicum in media supplemented with riboflavin (1) 
suggested that this pathway involves cleavage of the ribose from the isoalloxazine ring 
and lumichrome (11) is not further utilized as a source of carbon or nitrogen (Figure 
3.3A). To identify the genes involved in this transformation, Dr. Hui Xu (former postdoc 
in Begley lab) prepared cosmid library of M. maritypicum genome in Streptomyces 
lividans as heterologous host and screened for riboflavin catabolism. Two different 
cosmid hits were identified during the screening process. Further experiments identified 
a 8.7kb fragment, which showed degradation of riboflavin to lumichrome (Figure 3.3B). 
The genes were annotated based on the biochemical characterization of enzymes in the 
pathway performed by Dr. Yindrila Chakrabarty (former graduate student in Begley lab). 
A) B) 
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Figure 3.3: Catabolism of riboflavin (1) in M. maritypicum. A) Riboflavin is catabolized 
to ribose (12, used for growth) and lumichrome (11, discarded in media). B) Genes in 
the 8.7kb fragment that includes the cluster involved in the above mentioned 
transformation. 
 
 
 
Table 3.1: Annotation of genes involved in riboflavin (1) catabolism based on 
biochemical characterization. 
Sr. No. gene Function 
1. rcaA Flavin kinase 
2. rcaB Flavin reductase 
3. rcaC PadR family transcriptional regulator 
4. rcaD Ribokinase 
5. rcaE Riboflavin lyase 
6. rcaF Transporter 
7. rcaG Transporter 
8. rcaH Unknown function 
9. rcaI Unknown function 
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3.2.3 Role of enzymes in the riboflavin catabolic gene cluster 
The reactions catalyzed by the enzymes mentioned in Table 3.1 are highlighted 
in Figure 3.4. RcaC regulates the expression of the gene cluster in the environment. 
RcaF and RcaG are involved in transportation of riboflavin (1) into the cell. RcaA 
phosphorylates 1 to FMN (2) in presence of ATP and RcaB reduces this FMN (2) in 
presence of NADH to form FMNH2 (74). RcaE utilizes this FMNH2 (74) as a cofactor 
and acts on substrate riboflavin (1) in presence of oxygen to form lumichrome (11) and 
ribose (12). RcaD catalyzes phosphorylation of ribose (12) to form ribose-5-phosphate 
(75), which channeled into the central metabolism of an organism. Lumichrome (11) is 
released in the environment where it has been previously shown to be involved in 
quorum sensing. In summary, this pathway cannibalizes the ribose side chain of 
riboflavin (1), which serves as a carbon source for the growth and survival of bacteria. 
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Figure 3.4: Role of all enzymes in the riboflavin catabolic gene cluster identified in M. 
maritypicum. RcaE cleaves the ribose from the isoalloxazine in a process involving 
phosphorylation (RcaA) and reduction (RcaB). Ribose (12) is further phosphorylated to 
ribose-5-phosphate (75, RcaD), which is used to sustain growth of the organism. 
 
 
 
 
The fundamental reaction between reduced flavins and O2 has been extensively 
studied since 1970s.62 It has been primarily observed that FMNH2 (74) initially transfers 
a single electron to O2 and generates a radical pair between flavin semiquinone (76) and 
superoxide radical (9). In some enzymes like oxidases, a second electron transfer event 
generates H2O2 and oxidized flavin, while in monooxygenases, the radical pair collapses 
to form C4a-flavin(hydro)peroxide (77). However, mechanistic studies on riboflavin 
lyase (RcaE) demonstrated that this enzyme utilizes the superoxide radical (9) generated 
using FMNH2 (74) and O2 to abstract a H-atom from the C1' of riboflavin (1) as shown 
in Figure 3.5B. RcaE is the first example of flavin dependent enzyme where it has been 
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demonstrated biochemically that it catalyzes H-atom abstraction from the substrate using 
superoxide radical (9).  
 
 
 
 
 
Figure 3.5: Superoxide radical mediated H-atom abstraction from C1' of riboflavin 
during the RcaE catalyzed reaction. A) Reduction of FMN (2) generates FMNH2 (74) 
which in presence of O2 forms flavin semiquinone radical (76) and superoxide radical 
(9) pair. This step is common between other flavin enzymes and RcaE. However, in all 
other cases except RcaE, the radical pair collapses to form C4a-flavin(hydro)peroxide 
(77). B) In RcaE, the superoxide radical (9) abstracts H-atom from the C1' of riboflavin 
generating 10 which is subsequently converted to lumichrome (11) and ribose (12). 
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3.3 Crystal structure of Riboflavin lyase (RcaE) 
To obtain further mechanistic insights into this superoxide radical (9) mediated 
transformation and to learn about the unique features of RcaE active site, we turned our 
attention to obtain the crystal structure of riboflavin lyase (RcaE). The crystals of apo 
RcaE were obtained at room temperature while the cofactor FMN was co-crystallized 
with RcaE at 4 °C as a dimer. Several attempts to obtain riboflavin (1) bound in the 
active site using co-crystallization and soaking methods were unsuccessful. One of the 
hypotheses for the failure to obtain 1 bound in the active site of RcaE was the low 
solubility (200 µM) of riboflavin (1) in buffer solutions. We developed several strategies 
to overcome the limitation of riboflavin solubility. One approach involved preparing 
riboflavin in situ from FMN (2) by adding a phosphatase. With this methodology, we 
were able to obtain ~2.5 mM RBF in buffer solution. Co-crystallization setup using this 
strategy yielded crystals with RBF (1) and FMN (1) bound in the active site of RcaE. 
The structures of all three forms of riboflavin lyase (RcaE) are shown in Figure 3.6. 
 
 
 
 
 
Figure 3.6: Structure of RcaE in its apo form (1.90 Å), FMN bound to RcaE (1.90 Å), 
and FMN + RBF bound to RcaE (1.75 Å). 
RcaE (apo) RcaE + FMN RcaE + FMN + RBF 
open open 
closed 
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 As shown in Figure 3.6, structures of RcaE in the apo form and FMN bound form 
are quite identical. The active site in both cases is wide open and exposed to solvent. 
However after binding of the substrate RBF (1), the residues between Gln 306 to Pro 
368 undergo movement and close on top of FMN + RBF thereby shielding it from bulk 
solvent. As shown in Figure 3.7, the electron density map of FMN + RBF bound RcaE 
illustrates that the phosphate group in FMN has migrated from C5' to C3' due to acidic 
crystallization buffer conditions (pH 6.0). The modified FMN was named ligand 9WY. 
 
 
 
 
 
Figure 3.7: Modeling the cofactor ligand in the active site electron density of RcaE. A) 
2FO-FC map of the cofactor in active site of RcaE contoured at 1.0σ. B) Model of FMN 
in the 2FO-FC map does not fit well. C) Model of 9WY fits accurately to the 2FO-FC map. 
 
 
 
  
A) B) C) 
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Table 3.2: Data collection and refinement statistics for RcaE. 
 RcaE (Apo form) RcaE + FMN RcaE + 9WY + RBF 
Data collection    
Space group P212121 P212121 P212121 
Cell dimensions      
    a, b, c (Å) 74.97, 109.49, 126.42 76.25, 113.47, 117.81 74.97, 108.80, 125.08 
    α, β, γ  (°)  90, 90, 90 90, 90, 90 90, 90, 90 
Resolution (Å) 64.48-1.90 
(1.96-1.90)* 
64.01-1.90 
(1.96-1.90)* 
64.30-1.75 
(1.81-1.75)* 
Rmerge 0.229 (2.965) 0.147 (1.758) 0.114 (3.591) 
I / σI 7.3 (1.3) 13.9 (2.7) 9.0 (0.8) 
Completeness (%) 100 (99.92) 99.2 (99.93) 99.6 (99.37) 
Redundancy 7.7 (7.9) 18.6 (18.6) 8.8 (8.8) 
    
Refinement    
Resolution (Å) 1.90 1.90 1.75 
No. reflections 82558 81065 102980 
Rwork / Rfree 0.171/0.209 0.155/0.193 0.177/0.206 
No. atoms    
    Protein 7459 7375 7437 
    Ligand/ion 35 62 116 
    Water 490 377 379 
B-factors    
    Protein 32.51 47.73 47.51 
    Ligand/ion 56.73 60.56 47.93 
    Water 36.97 44.67 46.90 
R.m.s. deviations    
    Bond lengths (Å) 0.006 0.006 0.006 
    Bond angles (°) 0.845 0.840 0.853 
*Values in parentheses are for highest-resolution shell. 
 
 
 
The active site pocket of RcaE is hydrophobic and the isoalloxazine rings of the 
two flavins are stacked within Van der waals distance as shown in Figure 3.8A. We did 
not observe any electron density for water or O2 near the reaction center i.e. near C4a or 
N5 of 9WY or C1' of RBF. A molecule of O2 is modeled close to this reactive center in 
the active site of RcaE (Figure 3.8B). During RcaE catalyzed reaction, a proton can be 
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transferred from N5 of FMNH2 (74) to the oxygen simultaneously while transferring an 
electron thus generating hydroperoxy radical (H-O-O). This radical is optimally located 
to abstract a H-atom from the C1' position of the substrate riboflavin (1). Thus the unique 
superoxide mediated transformation in RcaE occurs due to alignment of FMN (2) and 
RBF (1) such that the formation of C4a-flavin(hydro)peroxide is sterically hindered 
which prevents biradical coupling between flavin semiquinone (76) and superoxide 
radical (9) species. Additionally, the C1' position of riboflavin is optimally oriented for 
H-atom abstraction by the hydroperoxy radical (H-O-O). 
 
 
 
 
 
 
 
 
 
Figure 3.8: Orientations of FMN and RBF in the active site of RcaE. A) Modified FMN 
and RBF are stacked within Van der waals distance in RcaE active site. B) Oxygen 
modeled close to the reaction center of FMN (modified) and RBF in the active site of 
RcaE. 
 
 
 
A) B) 
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3.4 Conclusion 
 We have identified a novel strain Microbacterium maritypicum G10 that is 
capable of catabolizing riboflavin (1, Vitamin B2).  The catabolic pathway involves 
cleavage of the ribose from the isoalloxazine ring of 1. The ribose (12) is used to sustain 
cell growth and the lumichrome (11) precipitates from the growth medium. The genes 
involved in this transformation were identified and their roles were established by in 
vitro characterization. Detailed mechanistic studies revealed a novel flavin dependent 
enzyme that catalyzes superoxide mediated H-atom abstraction from substrate riboflavin 
(1). Structural studies demonstrate that this novel reactivity of RcaE is a consequence of 
the orientations of substrate RBF (1) and cofactor FMN (2) in the active site such that 
formation of C4a-flavin(hydro)peroxide is sterically hindered. 
 Recently, the whole genome sequence of Devosia riboflavina was deposited in 
the NCBI database.63 BLAST analysis of RcaE from Microbacterium maritypicum with 
the whole genome sequence revealed the ortholog from Devosia riboflavina (Figure 3.9). 
The neighboring genes of RcaE that are involved in riboflavin catabolism where also 
found in D. riboflavina. This suggests that the riboflavin catabolic pathway identified in 
this study is identical to the one present in D. riboflavina. Thus, ~72 years after the first 
report of riboflavin catabolism, the gene cluster involved in this transformation has been 
identified and characterized. This study paves the way for further studies on alternate 
riboflavin catabolic pathways, which were previously reported but the strains were lost. 
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Figure 3.9: Sequence alignment of riboflavin lyase enzyme from Microbacterium 
maritypicum and Devosia riboflavina. 
 
 
 
 
3.5 Experimental procedures 
Materials: All chemicals were purchased from Sigma-Aldrich (now 
MilliporeSigma) unless specified otherwise. Nutrient Broth (NB) was from Difco. M9 
media was supplied by VWR. Kanamycin was from Teknova and IPTG was obtained 
from Lab scientific Inc. HPLC and LC-MS solvents were purchased from EMD and 
were used without further purification. Histrap column (5 ml) was obtained from GE 
healthcare. Econo-Pack 10 DG desalting columns were purchased from Bio-Rad 
Laboratories. Large cultures were grown and overexpressed in 2.5 L baffled ultra yield 
flasks from Thomson Instrument Company.  
 
Growth studies on Microbacterium maritypicum G10: The strain was grown 
overnight in NB media at 30 °C. 100 µl of this seed culture was added to a 50 ml M9 
media (with or without NH4Cl) supplemented either with glucose or riboflavin (1) in a 
250 ml Erlenmeyer flask. The cultures were incubated at 30 °C for ~48 hr with shaking. 
The amount of riboflavin supplemented was in the range of 1-5 mg/50 ml M9 media. 
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Growth curves for M. maritypicum were obtained by measuring absorbance at 600 nm in 
UV-Vis spectrophotometer. For HPLC analysis, the spent media was passed through a 
10kda filter. For quantitation of lumichrome (11) accumulated in the media, 500 µl of 
media was mixed with 500 µl of 1N KOH solution. The samples were then transferred to 
quartz cuvettes and UV-Vis spectrum was recorded between 200 – 800 nm. A 
calibration curve was prepared in a similar manner with authentic standard of 
lumichrome (11). These experiments demonstrated that the lumichrome (11) is not 
degraded further by M. maritypicum. 
 
HPLC parameters: An Agilent 1260 HPLC equipped with a quaternary pump 
was used. The system included a diode array UV-Vis detector and chromatograms were 
detected using absorbance at 220 nm, 254 nm, 260 nm, 280 nm, 340 nm, 370 nm and 
450 nm. Analysis was performed ZORBAX Eclipse XDB-C18 column (15 cm x 4.6 
mm, 5 μm particles, Agilent Technologies). Data was processed using ChemStation ver. 
B.04.01 SP1 (Agilent technologies). 
 
HPLC conditions: 
A- Water 
B- 100 mM Potassium phosphate buffer, pH 6.6 
C- Methanol 
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HPLC method: (Flow rate = 1 ml/min) 
0 min – 10% A 90% B, 2 min – 10% A 90% B, 12 min – 15% A 10% B 75% C, 17 min 
– 15% A 10% B 75% C, 18.5 min - 90% A 10% B, 20 min - 90% A 10% B, 25 min - 
90% A 10% B. 
 
Orthologs for crystallization of RcaE: Initial crystallization trials did not yield 
any hits for crystals of RcaE with the enzyme from M. maritypicum. Thus, following 
orthologs of RcaE were identified using BLAST search and gene synthesized from 
GenScript. All of these genes are currently annotated as Hypothetical proteins. 
Herbiconioux sp. YR403 (71% identity), Marine actinobacterium PHSC20C1 (70% 
identity), Devosia riboflavina (67% identity), Leifsonia aquatic (72% identity) and 
Kitasatospora setae (68% identity). These genes were cloned in pTHT vector (modified 
pET28b vector with TEV protease cleavage site after His-tag at the N-terminus).  
 
Overexpression and purification of enzymes: The respective plasmids were 
transformed into BL21(DE3) competent cells of E.coli using electroporation technique. 
Starter cultures were grown overnight in LB media containing kanamycin (40 μg/ml). 
30 ml of this culture was added to 3 L LB media (2 x 1.5 L flasks) with antibiotics and 
grown at 37 °C with shaking (180 rpm) till OD600~0.6.  The flasks were then incubated 
at 4 °C for ~2 hr without shaking. Cultures were then induced with 500 μM IPTG 
followed by incubation at 15 °C for ~14 hr with shaking at 180 rpm. The cells were 
harvested by centrifugation at 9,000 rpm for 10 min and stored in liquid nitrogen until 
further use. Typical yield was ~9 gm of cell pellet (wet weight) from 3 L cell culture.  
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For purification, the cell pellets were thawed and resuspended in 40-50 ml of 
lysis buffer (100 mM Tris.HCl, 150 mM NaCl, pH 7.5) at room temperature in the 
presence of lysozyme (6-8 mg). The suspension was stirred for ~1.5 hr on an ice-bath 
and further sonicated to lyse the cells. Cell debris was removed by centrifugation at 
18,000 rpm for 20min and the lysate was filtered using 0.22 µm filters. The filtered 
lysate was loaded onto a His-trap column pre-equilibrated with lysis buffer. The column 
was washed with 10 column volumes of wash buffer (100 mM Tris.HCl, 20 mM 
imidazole, 150 mM NaCl, pH 7.5). The protein was then eluted from the his-trap column 
with elution buffer (100 mM Tris.HCl, 250 mM imidazole, 150 mM NaCl, pH 7.5). 
Protein containing fractions were identified using Bradford reagent. They were pooled 
together and concentrated using 15 ml 10kda filters. The concentrated protein was buffer 
exchanged to 50 mM Tris.HCl, 10% glycerol, pH 7.5 using the Econo-Pac 10DG 
desalting column. 
After desalting RcaE, purified TEV protease was added to it in the ratio 
TEV:CmoJ = 1:10 and incubated at 30 °C for 4 hr. The solution of proteins was passed 
through Ni-NTA column, which was pre equilibrated with (100 mM Tris, 150 mM 
NaCl, pH 7.5). Histag cleaved RcaE was eluted from the column using 100 mM Tris, 20 
mM imidazole, 150 mM NaCl, pH 7.5 and further desalted into 10 mM Tris, pH 7.5 
buffer. The enzyme was used directly for setting up crystallization trials. The enzyme at 
-80 °C yielded poor crystals. Protein concentration was determined by measuring the 
absorbance at 280 nm (A280) and utilizing the extinction coefficient calculated using 
ProtParam tool of the ExPASy proteomics server. The function of all these orthologs 
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was confirmed by carrying out biochemical assays. All purified enzymes used riboflavin 
(1) as a substrate in presence of RcaB (reductase), FMN and NADH. Ribose (12) and 
lumichrome (11) were formed as products. 
 
Crystallization of RcaE orthologs: Crystallization trials were setup using 
commercial kits and hanging drop diffusion method. Enzyme concentration was kept in 
the range of ~13-15 mg/ml. Few hits were obtained with the Herbiconioux sp. YR403 
ortholog and were optimized further optimized to yield better quality crystals. 
 
Apo RcaE: 2.5 µl of reservoir solution was added to 2.5 µl of purified RcaE on 
the coverslip and sealed on top of a reservoir containing 100 mM BisTris-HCl pH 6.0 
and 1.7 M (NH4)2SO4 at 25°C. Rod shaped crystals were obtained after one week which 
grew larger for ~15 days. 
 
RcaE with FMN: A stock solution of 15 mg/ml protein with 2 mM FMN in 10 
mM Tris-HCl, pH 7.5 was prepared. Crystallization was setup at 4 °C in a 24-well plate. 
The reservoir solution contained 100 mM BisTris-HCl pH 6.5, 45% Polypropylene 
glycol P400. Diamond shaped crystals appeared after a week which grew larger for ~15 
days. 
 
RcaE with RBF and FMN: The solubility of riboflavin in aqueous solution is 
quite low (~200uM). Co-crystallization and soaking experiments with the above-
mentioned conditions did not yield a riboflavin bound structure. To obtain a 
concentrated solution of riboflavin, 3 mM FMN was dissolved in 10 mM Tris-HCl pH 
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7.5 buffer and treated with Calf-intestinal Phosphatase (CIP) at 37 °C. After ~2 hr, CIP 
was inactivated by heating at 65 °C for 20 min. This strategy resulted in 3 mM stock 
solution of riboflavin. This was used to prepare the final stock solution of 15 mg/ml 
protein, 2 mM FMN and 2 mM RBF in 10 mM Tris-HCl, pH 7.5. Crystallization was 
setup with reservoir containing 100 mM BisTri-HCl pH 6.0 and 1.9 M (NH4)2SO4 at 
25°C. Thick rod shaped crystals were obtained after four days which grew larger for ~15 
days. 
Glycerol was used as a cryoprotectant while preparing samples for X-ray diffraction. 
 
Collection of X-ray diffraction data: All X-ray diffraction data was collected at 
the Advanced Photon Source (APS), Argonne National laboratory. Crystals were 
diffracted at 100 K, at the 23-ID-D beamline using the PILATUS3 6M detector and a 
wavelength of λ= 1.033 Å. Diffraction data was collected for 240-360 frames and was 
recorded in a shutterless mode at the rate of one degree/sec. Datasets were integrated and 
scaled using iMosflm. 
 
Structure determination and refinement: The structure of RcaE bound with 
FMN was determined by molecular replacement using published structure of LadA PDB 
id 3B9O (40% sequence similarity with RcaE) as the starting model. The structures were 
refined iteratively using programs like PHENIX and COOT. The model thus generated 
was used as a starting model for RcaE (apo form) and RcaE bound with RBF and FMN. 
The final refinement statistics are summarized in Table 3.2. 
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4. MECHANISTIC STUDIES ON THE REACTION CATALYZED BY 
TRYPTOPHAN LYASE (NOSL)* 
 
4.1 Introduction to radical S-adenosyl-L-methionine (SAM) enzymes64 
Biological transformations often involve radical mechanisms.65 Some of the most 
intensively studied systems include metalloenzymes like cytochrome P450’s66 and 
alkane mono-oxygenases,67 ribonucleotide reductase,68 flavoenzymes69 and vitamin B12 
dependent enzymes.70 In 2001, enzymes utilizing [4Fe-4S] cluster and S-
adenosylmethionine (SAM) that catalyze diverse radical reactions were classified as a 
superfamily.10 With rapid progress in sequencing of bacterial genomes,71 today over 
165,000 enzymes are classified into this superfamily. Almost all known radical SAM 
enzymes (except Dph272 and glycerol dehydratase activating enzyme73), utilize S-
adenosyl-L-methionine (4, SAM) as a source to generate the 5ʹ-deoxyadenosyl radical 
(6, Ado). The 5′-deoxyadenosyl radical (6) abstracts a H-atom either from substrate or 
enzyme to initiate the desired transformation. Radical 6 is also found in various vitamin 
B12 dependent enzymes and is present across all kingdoms of life.74  
 
 
*Reprinted in parts with permission from “Tryptophan Lyase (NosL): Mechanistic 
Insights from Substrate Analogues and Mutagenesis” by Bhandari, D. M., Xu, H., 
Nicolet, Y., Fontecilla-Camps, J. C., & Begley, T. P. Biochemistry, 2015, 54(31), 4767-
4769. Copyright 2015 American Chemical Society and from “Mechanistic Studies on 
Tryptophan Lyase (NosL): Identification of Cyanide as a Reaction Product” by 
Bhandari, D. M., Fedoseyenko, D., & Begley, T. P. J. Am. Chem. Soc. 2017, (manuscript 
submitted). Copyright 2017 American Chemical Society. 
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Most enzymes in radical SAM superfamily have a characteristic CX3CX2C motif 
(Figure 4.1B).12 The three-cysteine residues coordinate with three of the four irons in a 
[4Fe-4S] cluster within the active site of these enzymes. SAM binds through the amine 
and carboxylate of the methionine moiety to the fourth iron of the [4Fe-4S] cluster. The 
cluster is sensitive to oxygen and in absence of a reducing agent; the cluster is in  [4Fe-
4S]+2 form. In presence of a suitable reducing agent, the cluster can be reduced to its 
catalytically active [4Fe-4S]+1 form. As shown in Figure 4.1A, the reduced cluster 
transfers one electron to the sulfonium center of SAM, which leads to homolytic 
cleavage of the S−5ʹC bond generating 5ʹ-deoxyadenosyl radical (6, Ado). In most 
cases, 6 initiates chemistry on the substrate and is converted to a product in a controlled 
fashion. The diverse chemistry catalysed by this family of enzymes signifies the strategy 
evolved by nature to fine tune the reactivity of unstable radical species and obtain 
products that would be otherwise inaccessible. 
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Figure 4.1: Introduction to the radical SAM enzymes. A) Reductive homolytic cleavage 
of SAM (4) leads to formation of the 5′-deoxyadenosyl radical (6) and methionine (5). 
B) Typical active site of a radical SAM enzyme showing binding of cysteines and SAM 
to the irons of the [4Fe-4S] cluster. 
 
 
 
4.2 Aromatic amino acid lyases subfamily13 
A subgroup (>1000 annotations by bioinformatics) in radical SAM superfamily 
consists of enzymes that generate fragments of aromatic amino acids and utilize them in 
their respective biosynthetic pathways. These include ThiH from prokaryotic thiamin 
biosynthetic pathway, HydG involved in maturation of H-cluster of hydrogenase, F0 
synthase or CofG/CofH from F420 biosynthesis and NosL from nosiheptide biosynthesis. 
As shown in Figure 4.2, ThiH, HydG and CofH utilize L-tyrosine (78) as a substrate 
while NosL uses L-tryptophan (13) as the substrate. ThiH catalyzes the formation of 
dehydroglycine (80), which gets incorporated into thiamin (81). HydG generates the 
cyanide (82) and carbon monoxide (83) ligands of the [Fe-Fe]-hydrogenase H-cluster 
(84). The p-cresol radical (85) generated by CofH is incorporated into cofactor F420 (86). 
NosL is involved in biosynthesis of 3-methyl-2-indolic acid (15), which is further 
incorporated into a thiopeptide antibiotic nosiheptide (89). 
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Figure 4.2: Examples of the aromatic amino acid lyases from radical SAM superfamily. 
A) ThiH catalyzes formation of dehydroglycine (80) which is incorporated into thiamin 
(81). B) HydG catalyzes formation of carbon monoxide (83) and cyanide (82) fragments 
which are incorporated into [Fe-Fe]-hydrogenase H-cluster (84). C) In CofH, the p-
cresol radical (85) is incorporated into cofactor F420 (86). D) NosL catalyzes formation 
of 3-methyl-2-indolic acid (15), a fragment of nosiheptide (89). 
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4.3 Background 
Nosiheptide (89)75 is a highly modified polythiazolyl heterocyclic peptide 
antibiotic active against highly resistant pathogenic strains of Staphylococcus aureus, 
Streptococcus pneumonia, Clostridium difficile and several enterococci.76 The precursor 
peptide is ribosomally encoded and the final molecule contains five thiazoles, a 
tetrasubstituted pyridine and an unusual indolic acid (see Figure 4.2D).77 Recently, the 
gene cluster involved in the biosynthesis of nosiheptide was identified and NosL was 
demonstrated to be the enzyme required for catalysis of the remarkable transformation of 
L-tryptophan (13) to 3-methyl-2-indolic acid (15).21 
Early reports on mechanism for this enzyme family proposed that the chemistry 
is initiated on substrate by abstraction of H-atom (by Ado) from phenolic O−H for 
ThiH, HydG and F0 synthase, and from indolic N−H for NosL (Figure 4.3A).78 This 
hypothesis was based on enzymatic reactions done in presence of deuterated substrates 
(C−H bonds labeled to C−D bonds). The 5ʹ-deoxyadenosine (93) thus generated did not 
show any deuterium label incorporation. Further, when the enzymatic reaction was 
performed in D2O buffer, incorporation of deuterium in 5ʹ-deoxyadenosine was 
observed.79 However, this only implies that Ado abstracts H-atom from a heteroatom 
on substrate in all enzymes of this family.  
Recently, crystal structure of NosL was obtained complexed with [4Fe-4S] 
cluster + SAM + L-tryptophan.22 As shown in Figure 4.3B, in the active site of NosL, 5ʹ-
C of adenosine from S-adenosyl-L-homocysteine (SAH) is 3.7 Å away from N-atom of 
amino group of L-tryptophan (13). This indicates that H-atom is abstracted from 
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nitrogen-atom of amino group instead of nitrogen-atom from indole ring of 13. Crystal 
structure of NosL is the first direct evidence of H-atom abstraction from the amino group 
of a substrate by the 5′-deoxyadenosyl radical (6) in the radical SAM superfamily. 
 
 
 
 
Figure 4.3: Early mechanistic studies on aromatic amino acid lyases. A) For tyrosine 
lyases it was proposed that the 5′-deoxyadenosyl radical (6) abstracts H-atom from the 
phenolic O-H group generating 90. B) In NosL catalyzed reaction, the 5′-deoxyadenosyl 
radical (6) was proposed to abstract a H-atom from indolic N-H of L-tryptophan 
generating 91. C) Active site architecture of NosL shows that the C5′ of SAM is close to 
the amino N-H instead of indolic N-H of L-tryptophan (13). 
 
 
 
 
4.4 Results and Discussion 
4.4.1 In vitro reconstitution of Tryptophan Lyase (NosL) 
When the NosL catalyzed reaction was carried out using L-tryptophan (13) as 
substrate and dithionite as the reductant, HPLC analysis showed primarily the formation 
of 3-methyl indole (92) while 3-methyl-2-indolic acid (15) was produced in small 
quantities and was characterized using LC-MS (Figure 4.4). Using excess dithionite 
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reduced the amount of 3-methyl-2-indolic acid (15) generated in comparison to 3-methyl 
indole (92). The higher ratio of 15 to 92, was obtained by lowering the amount of 
dithionite to 1-2 equivalents of the enzyme concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Analysis of the NosL-catalyzed reaction with L-tryptophan. A) HPLC 
chromatogram at 288 nm showing consumption of L-tryptophan (13) and formation of 
5′-deoxyadenosine (Ado-H) and 3-methylindole (92) when all components of the 
enzymatic reaction were present. B) HPLC chromatogram of authentic standard of 3-
methylindole (92) and its co-injection with the ‘full reaction’ sample. C) LC-MS 
analysis showing the extracted ion chromatogram (EIC) [M-H]- = 174.0 Da indicating 
formation of 3-methyl-2-indolic acid (15) only when all components of the enzymatic 
reaction were present. D) MS of 3-methyl-2-indolic acid (15) generated in the ‘full 
reaction’ sample. 
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However, when the NosL-catalyzed reaction with L-tryptophan (13) was 
performed in the presence of the flavodoxin system (FldA/FldR), HPLC analysis 
revealed that in the ‘full reaction’ sample, 3-methyl-2-indolic acid (15) was generated as 
the major product while 3-methylindole (92) was produced in small quantities. As shown 
in Figure 4.5, formation of 3-methyl-2-indolic acid (15) was further confirmed by LC-
MS and co-injection with its authentic standard. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Analysis of the NosL-catalyzed reaction with L-tryptophan (13) in the 
presence the FldA/R. A) HPLC analysis at 288 nm showing the formation of 3-methyl-
2-indolic acid (15) and 3-methylindole (92) in the ‘full reaction’ sample. B) LC-MS 
analysis showing EIC [M-H]- = 174.0 Da demonstrating the formation of 3-methyl-2-
indolic acid (15) only when all components of the enzymatic reaction are present. C) 
LC-MS analysis showing EIC [M-H]- = 174.0 Da confirming the formation of 15 by co-
injection with the authentic standard. D) MS of 3-methyl-2-indolic acid (15) generated in 
the ‘full reaction’ sample. 
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4.4.2 Position of the H-atom abstraction in the NosL catalyzed reaction80 
The structure of NosL suggests that the 5′-deoxyadenosyl radical (6) abstracts a 
H-atom from the amino rather than from the indolic NH of tryptophan as previously 
proposed. To test this prediction in a biochemical assay, the NosL reaction was run using 
a tryptophan analog 94 in which the indole NH is replaced by sulfur. This reaction 
generated 95 and 96 as products consistent with hydrogen atom abstraction from the 
amino group (Figure 4.7). Another study using the benzofuran analog of tryptophan gave 
similar results.81 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Analysis of the NosL enzymatic reaction with L-3-benzothienylalanine (94). 
A) Scheme showing products of reaction with 94 as substrate. B) HPLC analysis of 
reaction mixture at 254 nm revealed formation of compounds 95 and 96 only in the 
presence of all the components. C) HPLC analysis showing co-injection of the authentic 
standard of 3-methylbenzothiophene (96) with the compound generated in the ‘full 
reaction’ sample. C) HPLC analysis showing co-injection of the authetic standard of 3-
methylbenzothiophene-2-carboxylic acid (95) with the compound generated in the 
enzymatic reaction. C) LC-MS analysis showing EIC [M-H]- = 191.0 Da confirming 
formation of 95. D) MS of 95 generated in the ‘full reaction’ sample. 
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Figure 4.7 continued. 
 
 
 
4.4.3 Reaction of NosL in deuterated buffer  
To confirm the position of H-atom abstraction from L-tryptophan (13) during the 
NosL catalyzed reaction, the enzymatic reaction was performed in 90% D2O buffer. As 
shown in Figure 4.8, LC-MS analysis of the 5′-deoxyadenosine (93, Ado-H) showed 
incorporation of multiple deuteriums from solvent. This observation is similar to reports 
on other aromatic amino acid lyases previously discussed: HydG, CofH and ThiH 
(unpublished). This demonstrates that the 5′-deoxyadenosyl radical (6) abstracts H-atom 
from a solvent exchangeable position of the substrate. 
C) 
Time (min) 
7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 Time [min]
0
2
4
6
8
4x10
Intens.
No NosL_Benzothio_neg_1-C,3_01_16930.d: EIC 191.0000±0.2 -All MS No substrate_NosL prep3_neg_1-C,4_01_16931.d: EIC 158.0±0.2 -All MS No SAM_Benzothio_neg_1-C,5_01_16932.d: EIC 191.0±0.2 -All MS
No Dithionite_Benzothio_neg_1-C,6_01_16933.d: EIC 191.0±0.2 -All MS Full Rxn_NaDit_Benzothio_neg_1-C,7_01_16934.d: EIC 190.9874±0.2 -All MS
E) 
D) 
Time (min) 
S
96
S
OH
O
95
S
O
O
95
[M-H]- = 191.0172
F) 
191.0177 
m/z 
S
O
O
95
[M-H]- = 191.0172
  78 
 
 
 
Figure 4.8: MS analysis of deuterium incorporation in 5′-deoxyadenosine (93). A) MS 
of the authentic standard of 93. B) MS of 93 generated in absence of substrate during the 
NosL-catalyzed reaction. One deuterium incorporation in 93 was observed. C) MS of 93 
generated during NosL catalyzed reaction in presence of L-tryptophan (13) as substrate. 
Incorporation of multiple (upto three) deuteria in 93 was observed. 
 
 
 
When the enzymatic reaction is carried out in deuterated buffer, all the solvent 
exchangeable protons will be replaced by deuterium. As shown in Figure 4.9, the 5′-
deoxyadenosyl radical (6, Ado) can abstract a deuterium atom from the amino group of 
the substrate thereby incorporating a deuterium into 5′-deoxyadenosine (93). The 
nitrogen-centered radical can further abstract a H-atom from 5′-deoxyadenosine. This 
hydrogen on the amino group can be exchanged with the deuterium present in the buffer. 
253.1120
252.1098 +MS, 12.4-12.5min #(737-740)
0
1
2
3
4
4x10
Intens.
246 248 250 252 254 256 258 m/z
253.1140
254.1162
252.1087
+MS, 12.6min #(748)
0.0
0.5
1.0
1.5
2.0
4x10
Intens.
246 248 250 252 254 256 258 m/z
253.1157
255.1279
256.1294
254.1215
252.1096
+MS, 12.6min #(750)
0
1
2
3
4
4x10
Intens.
246 248 250 252 254 256 258 m/z
HO OH
O N
N
NH3
NN
H
H
H
5'-deoxyadenosine
[M+H]+ = 252.1091
93
A) 
B) 
C) 
  79 
The 5′-deoxyadenosyl radical (6, Ado) can abstract another deuterium atom from the 
amino group and so on. Thus the reversibility of H-atom abstraction between the 
substrate and 5′-deoxyadenosyl radical (Ado) leads to the incorporation of multiple 
deuteria into 5′-deoxyadenosine when the enzymatic reaction is carried out in the 
deuterated buffer.82 
 
 
 
 
Figure 4.9: Mechanistic proposal for the NosL-catalyzed multiple deuterium 
incorporation in 5′-deoxyadenosine (Ado-H). [A = Adenine] 
 
 
 
4.4.4 Mechanistic proposal for the NosL catalyzed reaction80 
Based on the previous studies and some preliminary biochemical studies 
discussed above, a mechanistic proposal for the NosL catalyzed reaction is shown in 
Figure 4.10. In this mechanism, the 5′-deoxyadenosyl radical (6, Ado) abstracts a H-
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atom from the amino group of 13 generating 14. β-bond scission of the Cα-Cβ bond 
generates radical 98 and dehydroglycine (80). Addition of 98 to 80 gives 99. A second 
β-bond scission generates 100, which then isomerizes to the product 15. The byproduct, 
radical 102, may abstract a hydrogen atom from an unidentified source to form imine 
103 which then undergoes hydrolysis to formaldehyde (87). This mechanism is 
supported by labeling experiments identifying the origin of key atoms in the product, by 
the trapping of radical 98 to give 92 and by a recent structure of the enzyme substrate 
complex, which suggests formation of 14 by H-atom abstraction instead of 91. 
 
 
 
 
Figure 4.10: Mechanistic proposal of the NosL-catalyzed reaction involving Cα-Cβ 
scission. 
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4.4.5 Regiochemical control of the NosL catalyzed reaction 
 
The amino centered radical of tryptophan could in principle undergo three 
possible beta scission reactions involving decarboxylation, deprotonation or Cα-Cβ bond 
cleavage. The crystal structure suggests that hydrogen bonding between the amino group 
and Arg 323 is likely to control the regiochemistry of this fragmentation reaction (Figure 
4.3C). To test this, we examined the reaction of NosL with D-tryptophan (104). With this 
compound, the amino group and the proton at Cα are interchanged thus removing the 
controlling hydrogen bond to Arg 323. When D-tryptophan (104) is used as a substrate, 
all three possible β-scission reactions occur to give 3-methylindole (92, Cα-Cβ bond 
cleavage), indole-3-pyruvic acid (111, Cα-H bond cleavage) and indole-3-acetaldehyde 
(108, decarboxylation) (Figures 4.11 – 4.13). Mechanistic proposals for the formation of 
these three products is shown in Figure 4.11A and 4.11B.83 
 
 
 
 
 
Figure 4.11: Determining regio-control of the NosL catalyzed reaction. A) Three 
possible β-scission reactions occurring from nitrogen centered radical in D-tryptophan 
(104). B) An alternate pathway for the formation of indole-3-pyruvic acid (111). 
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Figure 4.12: Analysis of the NosL reaction with 104. A) HPLC analysis at 280 nm 
showing consumption of 104 in the presence of all components of the enzymatic 
reaction. B) HPLC chromatogram showing formation of 3-methylindole (92) and indole-
3-pyruvic acid (111) in the ‘full reaction’ sample. MTA is an impurity present in 
commercial SAM. C) LC-MS analysis showing EIC [M-H]- = 202.0 Da confirming the 
formation of 111 in the ‘full reaction’ sample. D) MS of 111 generated during the NosL-
catalyzed reaction. E) LC-MS analysis showing EIC [M-H]- = 158.0 Da indicating 
formation of indole-3-acetaldehyde (108) in the ‘full reaction’ sample. F) MS of 108 
generated enzymatically.  
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To confirm the formation of indole-3-acetaldehyde (108), 100ul of the ‘full 
reaction’ sample was treated with 1mg of NaBH4 and incubated at room temp for ~1 hr. 
Analysis of this reduced sample by LC-MS showed the disappearance of the signal 
corresponding to 108 and formation of a new signal corresponding to tryptophol (113), 
Figure 4.13. Formation of 113 was further confirmed by co-injection with its authentic 
standard. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13: Analysis of the tryptophol (113) generated by NaBH4 reduction of indole-
3-acetaldehyde (108) during the NosL reaction with D-tryptophan (104). A) Scheme 
depicting reduction of 108 by NaBH4. B) After treatment of the ‘full reaction’ sample 
with NaBH4, LC-MS analysis showed loss of signal EIC [M-H]- = 158.0 Da and a new 
signal with [M-H]- = 160.0 Da was observed. C) LC-MS analysis showing EIC [M-H]- = 
160.0 corresponding to the authentic standard of 113 and its co-injection with NaBH4 
reduced ‘full reaction’ sample. A single peak confirms formation of 113. D) MS of 113 
generated after NaBH4 reduction of the ‘full reaction’ sample.  
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4.4.6 Role of active site residues in the NosL catalyzed reaction 
The key interactions between tryptophan and the enzyme are shown in Figure 
4.3C. The role of all active site residues in catalysis was probed using mutagenesis. Arg 
323 is hydrogen bonded to the amino and carboxylate groups of L-tryptophan (13). This 
interaction is likely to play a role in controlling the regiochemistry of the β-scission 
reaction and in binding the glycine imine for reaction at C2 of the indole. In support of 
this, the R323K mutant produces indole-3-pyruvic acid (111) instead of 15 and no 
products arising from either Cα-Cβ bond scission or Cα-C(O) bond scission were 
detected (Figure 4.14). 
 
 
 
 
 
 
 
Figure 4.14: Analysis of the enzymatic reaction catalyzed by the NosL R323K mutant 
with L-tryptophan. A) Mechanistic proposal for the formation of 111 from L-tryptophan. 
B) HPLC analysis of the enzymatic reaction at 280 nm shows formation of indole-3-
pyruvic acid (111) and an unidentified new signal only in the ‘full reaction’ sample. C) 
LC-MS analysis showing EIC [M-H]- = 202.0 Da confirming the generation of 111.  
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Figure 4.14 continued. 
 
 
 
 Additional variants of the NosL active site namely Y90F, C200A and S340A 
were found to generate 3-methyl-2-indolic acid (15) from L-tryptophan (13) as shown in 
Figure 4.15. This suggests that these resides are not directly involved in NosL catalysis. 
 
 
 
 
 
Figure 4.15: Analysis of the NosL active site variants. A) LC-MS analysis of Y90F 
showing EIC [M-H]- = 174.0 Da confirming the formation of 15. B) MS of 15 generated 
during the enzymatic reaction with Y90F. C) LC-MS analysis of C200A showing EIC 
[M-H]- = 174.0 Da confirming the formation of 15. D) MS of 15 generated during the 
enzymatic reaction with C200A. E) LC-MS analysis of S340A showing EIC [M-H]- = 
174.0 Da confirming the formation of 15. 
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Figure 4.15 continued. 
 
 
 
4.4.7 Reaction of NosL with L-tryptophan thiocarboxylate (115) 
To gain further insights into the β-scission after H-atom abstraction from the 
amino group (Figure 4.16), we investigated the reaction of NosL in presence of L-
tryptophan thiocarboxylate (115). If the reaction proceeds via Cα-Cβ bond scission, it 
will generate 3-methylindole (92) while if it proceeds via Cα-C(O) bond scission, it will 
lead to the formation of indole-3-acetaldehyde (108). HPLC analysis of the NosL 
tryptophan thiocarboxylate reaction mixture showed complete substrate consumption 
(Figure 4.17) and formation of a new product, which was identified as aldehyde 108 
based on LC-MS analysis. This product was also reduced with NaBH4 to form alcohol 
113, which was chromatographically identical with an authentic standard. Remarkably, 
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3-methylindole (92), the major product formed with L-tryptophan, was not detected. 
Addition of the thioformyl radical (118) to 3-methylindole (92) is retarded due to 
stabilization by the sulfur and leads to the trapping of 108. 
 
 
 
 
Figure 4.16: After H-atom abstraction from the amino group of L-tryptophan, two 
possible β-scission reactions will lead to different products. 
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Figure 4.17: Analysis of NosL catalyzed reaction with L-tryptophan thiocarboxylate 
(115). A) Mechanistic proposal for the Cα-C(O) bond scission. B) HPLC analysis at 280 
nm shows complete consumption of substrate 115 and formation of aldehyde product 
108. C) LC-MS analysis showing EIC [M-H]- = 158 Da suggesting the formation of 108. 
D) MS of reaction product 108 in negative mode. E) Co-injection of 113 with authentic 
standard confirming its formation after NaBH4 reduction. F) LC-MS analysis of the ‘Full 
Rxn’ sample after treating with NaBH4 showing reduction of aldehyde 108 to tryptophol 
(113).  
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We have previously observed the formation of aldehyde 108 in the reaction of D-
tryptophan with NosL but viewed this fragmentation as an off-pathway reaction because 
of the altered tryptophan stereochemistry. Aldehyde 108 however was not previously 
detected from L-tryptophan (13). Motivated by the results of the tryptophan 
thiocarboxylate experiment, we repeated the NosL/L-tryptophan reaction (with all 
variants of NosL) using fluorescence rather than absorbance for product detection to 
give greater sensitivity for the detection of aldehyde 108. HPLC analysis of the resulting 
reaction mixture showed a new signal at 24.3 min (Ex = 270 nm, Em = 352 nm). LC-MS 
analysis confirmed the identification of this product as the aldehyde 108 (Figure 4.18). 
 
 
 
 
 
 
Figure 4.18: Detection of aldehyde 108 in NosL and its variants. A) Fluorescence 
analysis at Ex = 270 nm and Em = 352 nm of NosL and its mutants showing formation 
of aldehyde 108 at 24.3 min. The aldehyde 108 was detected in all variants except NosL 
R323K. B) LC-MS analysis showing EIC [M-H]- = 158 Da confirming formation of 108 
in NosL WT. C) MS of aldehyde 108 generated with NosL WT. 
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Figure 4.18 continued. 
 
 
 
4.4.8 Reaction of NosL with 2'-chloro-L-tryptophan (119) and 2'-bromo-L-
tryptophan (121) 
2'-Halo-L-tryptophan (Br, Cl) was designed to trap a radical on C3′ by exploiting 
the very rapid cleavage of a C-halogen bond beta to a radical center.84-85 When the NosL 
reaction was carried out with 2'-chloro-L-tryptophan (119), HPLC analysis showed 
complete substrate consumption and exclusive formation of a new product was observed 
(Figure 4.19). This product was identified as 3-methylindole-2-carboxylic acid (15) by 
LC-MS and chromatographic identity to an authentic standard. Similar results were 
obtained with 2'-bromo-L-tryptophan (121). 
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Figure 4.19: Analysis of the NosL reaction with 2'-chloro-L-tryptophan (119). A) HPLC 
analysis at 280 nm shows complete consumption of substrate 119 and formation of 15 in 
the ‘Full Rxn’ sample. B) Co-injection of ‘Full Rxn’ sample with authentic standard of 
15 confirming its identity. C) LC-MS analysis showing EIC [M-H]- = 174 Da confirming 
formation of product 15. E) MS of product 15. 
 
 
 
When 2'-chloro-L-tryptophan (119) was used as a substrate for the mutants of 
NosL, 3-methyl-2-indolic acid (15) was observed as the exclusive product with NosL 
Y90A, Y90F, C200A, S340A variants (Figure 4.20). Additionally, analogous to the 
reaction with L-tryptophan (13), NosL R323K variant generated the corresponding 
ketoacid 120 with 119 as a substrate. 
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Figure 4.20: Analysis of the NosL variants with 2'-chloro-L-tryptophan (119). A) HPLC 
analysis at 280 nm of the reaction of NosL mutants with 119 showing formation of 15 in 
all variants except NosL R323K. B) LC-MS analysis showing EIC [M-H]- = 236.0 Da 
suggesting that the new product is 120 in NosL R323K variant. C) MS of product 120. 
 
 
 
During NosL catalyzed reaction with 2'-bromo-L-tryptophan (121), complete 
conversion to 3-methyl-2-indolic acid (15) was observed (Figure 4.21). Further studies 
of NosL mutants with 121 showed identical behavior as observed with 119 i.e. NosL 
Y90A, Y90F, C200A, S340A variants generated 3-methylindole-2-carboxylic acid (15) 
while NosL R323K formed the corresponding ketoacid. 
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Figure 4.21: Analysis of the NosL reaction with 2'-bromo-L-tryptophan (121). A) HPLC 
analysis at 280 nm showing complete consumption of 121 in ‘Full Rxn’ sample, 
concomitant with formation of 15. B) LC-MS analysis showing EIC [M-H]- = 154 Da 
confirming formation of 15. C) MS of product 15. 
 
 
 
The enzymatic reaction mixture was next analyzed for the products derived from 
C2 and the C2 amino group of 2'-chloro-L-tryptophan (119). Formaldehyde, carbon 
monoxide and cyanide were each considered as possible products. The enzymatic 
reaction, treated with purpald or dansylhydrazine failed to yield the corresponding 
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formaldehyde adducts, thus excluding formaldehyde as a byproduct. Reduced 
hemoglobin also failed to detect carbon monoxide.86 To test for cyanide (82) formation, 
the enzymatic reaction was treated with orthonapthalene dicarboxaldehyde (122) and 
taurine (123) to convert cyanide to the fluorescent derivative 124 (Figure 4.22).87 HPLC 
analysis using fluorescence (Ex = 418 nm, Em = 454 nm) showed a new product 
confirmed as 124 by LC-MS and chromatographic identity with an authentic standard. 
The ratio of cyanide (82) to 3-methylindole-2-carboxylic acid (15) was ~ 0.9:1. 
 
 
 
 
 
 
 
 
Figure 4.22: Detection of cyanide (82) as a byproduct of the NosL catalyzed reaction 
with 2'-chloro-L-tryptophan (119). A) Reaction used to convert cyanide to a fluorescent 
product 124. B) HPLC analysis of the NosL/2'-chloro-L-tryptophan (119) reaction 
mixture after derivatization as shown in panel A. C) LC-MS analysis after derivatization 
showing EIC [M-H]- = 299 Da suggests formation of 124. D) MS of the derivative 124. 
E) LC-MS analysis showing co-injection of derivatized ‘Full Rxn’ sample with authentic 
standard of 124 generated using cyanide (82). 
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Figure 4.22 continued. 
 
 
 
 
Figure 4.23: Mechanistic proposal of the NosL catalyzed reaction with 2'-chloro-L-
tryptophan (119). 
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A mechanistic proposal for the NosL catalyzed reaction with 2'-chloro-L-
tryptophan (119) is shown in Figure 4.23. Hydrogen atom abstraction from the amino 
group of 2'-chloro-L-tryptophan gives 125. A β-scission reaction releases the formyl 
radical (114), which then adds to C2' of the indole to give 127. Loss of H2CN+ from 127 
gives the stabilized radical anion 128 which can also be viewed as an aryl radical anion 
128'.  Protonation at C3, potentially using the strongly acidic H2CN+, followed by loss of 
a chlorine atom completes the reaction. 
 
4.4.9 Reaction of NosL with 2'-methyl-L-tryptophan (130) 
 When the reaction of NosL was performed with 2'-methyl-L-tryptophan (130), 
formation of 2,3-dimethyl indole (131) and cyanide (82) was observed (Figure 4.24). 
 
 
 
 
 
Figure 4.24: HPLC analysis of the NosL reaction with 2'-methyl-L-tryptophan (130). A) 
HPLC analysis at 288 nm shows consumption of substrate and formation of a new signal 
at 29.5 min. B) HPLC analysis at 288 nm shows co-migration of the authentic standard 
of 2,3-dimethyl indole (131) and the compound generated during NosL reaction with 
130. C) Fluorescence HPLC analysis at Ex = 418 nm and Em = 454 nm confirms 
formation of cyanide (82) in ‘Full Rxn’ sample by trapping 124. 
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Figure 4.24 continued. 
 
 
 
4.4.10 Analysis of the NosL reaction using 13C and 15N isotopologues of L-
tryptophan 
Next we turned our attention to the identification of the products of dithionite-
reduced NosL reaction with L-tryptophan (13). It was reported that 3-methylindole (92) 
is the major heterocyclic product of this reaction and glyoxal (101), formaldehyde (87) 
and ammonia (88) were assumed to be the C1/C2, the C2 and C2 amino-derived products 
respectively, based on the detection, at trace levels by LC-MS, of glyoxal (101) and 
formaldehyde (87) in the reaction mixture (Figure 4.2D). The quantitative detection of 
cyanide (82) as a NosL reaction product in the 2'-chloro-L-tryptophan (119) and 2'-
methyl-L-tryptophan (130) reactions cast doubt on this assumption. Isotopologues of L-tryptophan (13) were synthesized chemo-enzymatically by 
feeding indole and isotopically labeled L-serine to tryptophan synthase in presence of 
PLP (Figure 4.25).88 Isotopologues [1,2,3-13C3, 2-amino-15N1]-L-tryptophan (13d) and 
[1-13C1]-L-tryptophan (13e) were synthesized using tryptophan synthase while [15N2]-L-
tryptophan (13f) was obtained commercially. 
Time (min) 
N
SO3
C
N
Ex = 418nm, Em = 454nm
124
C) 
  98 
 
Figure 4.25: Isotopologues of L-tryptophan (13). A) Scheme depicting chemo-
enzymatic synthesis of the isotopologues using tryptophan synthase. B) Isotopologues 
used to investigate products of the NosL catalyzed reaction. 
 
 
 
When the NosL reaction was performed with [1,2,3-13C3, 2-amino-15N1]-L-
tryptophan (13d), 13C-NMR analysis of the reaction mixture revealed only two new 
signals (8 ppm and 160 ppm, Figure 4.26A). The 8 ppm signal was assigned to the 
methyl group of 3-methylindole (92) and the 160 ppm signal was assigned to cyanide 
(82) and/or bicarbonate by spiking with authentic standards and recording the spectra. 
 
 
 
 
 
Figure 4.26: 13C-NMR analysis of NosL reaction with [1,2,3-13C3, 2-amino-15N1]-L-
tryptophan (13d). A) NMR spectra of the substrate 13d. B) Full reaction sample shows 
two signals at 8 ppm and 160 ppm. C) Full reaction sample spiked with 20 mM KCN 
(final conc.) shows a single peak at 160 ppm. Magnified region at 160 ppm is shown in 
the small panel. D) Full reaction sample spiked with 50 mM NaHCO3 (final conc.) 
shows a single peak at 160 ppm. Region at 160 ppm is magnified in the small panel. 
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Figure 4.26 continued. 
 
 
 
Next, 13C-NMR spectra were recorded of the NosL catalyzed reaction with [1-
13C1]-L-tryptophan (13e). The sample was further spiked with NaHCO3 and a single 
signal was observed at 160 ppm (Figure 4.27). This confirms that the C1 fragment of L-
tryptophan (13) is lost as CO2, which is trapped as bicarbonate under buffer conditions. 
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Figure 4.27: 13C-NMR analysis of NosL reaction with [1-13C1]-L-tryptophan (13e). A) 
NMR spectra of the substrate 13e. B) Full reaction sample shows formation of a unique 
signal at 160 ppm. C) Full reaction sample was spiked with 50 mM NaHCO3. It shows a 
unique signal at 160 ppm confirming the identity of the C1 fragment. 
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To test formation of CO2/bicarbonate (134), we treated the NosL enzymatic 
reaction with phosphoenolpyruvate carboxylase (PEPC) in presence of 
phosphoenolpyruvate (135). Any bicarbonate present in solution will be derivatized by 
phosphoenolpyruvate (135) and generate oxaloacetate (136) as shown in Figure 4.28. To 
establish the identity of oxaloacetate (136), the reaction mixture was derivatized with o-
(2,3,4,5,6-pentafluorobenzyl)hydroxylamine.HCl (137, PFBHA) and analyzed on LC-
MS.89  
 
 
 
 
 
 
Figure 4.28: Derivatization of bicarbonate using PEPCarboxylase. A) Scheme of PEPC 
catalyzed reaction, showing formation of oxaloacetate (136). B) Derivatization of 
oxaloacetate (136) with PFBHA (137) for LC-MS detection. 
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 Reaction of NosL with [1-13C1]-L-tryptophan (13e) followed by PEPC treatment 
suggests formation of CO2/bicarbonate from C1 fragment of L-tryptophan (Figure 4.29). 
Thus PEPC can be used to derivatize all the CO2/bicarbonate generated. 
 
 
 
 
 
 
Figure 4.29: 13C-NMR analysis of NosL reaction with [1-13C1]-L-tryptophan (13e). A) 
NMR of the substrate 13e. B) NMR of the Full reaction sample when 13e is used as a 
substrate shows formation of a single peak at 160 ppm. C) When the full reaction sample 
is treated with PEPC, the signal at 160 ppm disappears and a new signal at 175 ppm is 
observed indicating formation of oxaloacetate (136).  
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Reaction of NosL with [1,2,3-13C3, 2-amino-15N1]-L-tryptophan (13d) followed 
by treatment with PEPC suggests formation of CO2/bicarbonate from the C1 fragment 
and CN from the C2 fragment of L-tryptophan (13). 
 
 
 
 
 
 
 
Figure 4.30: 13C-NMR analysis of NosL reaction with [1,2,3-13C3, 2-amino-15N1]-L-
tryptophan (13d). A) NMR of the substrate [1,2,3-13C3, 2-amino-15N1]-L-tryptophan 
(13d). B) NMR of the Full reaction sample when 13d is used as a substrate shows 
formation of a single peak at 160 ppm. C) When the full reaction sample is treated with 
PEPC, a new signal appears at 175 ppm indicates formation of oxaloacetate while signal 
at 160 ppm indicates -CN formation.  
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 The bicarbonate that is converted to oxaloacetate using PEPC was further 
derivatized with PFBHA (137) for LC-MS analysis of adduct (138). Figure 4.31 shows 
MS spectra of 138 generated when unlabeled L-tryptophan (13), [1,2,3-13C3, 2-amino-
15N1]-L-tryptophan (13d) and [1-13C1]-L-tryptophan (13e) were used as substrates. 
 
 
 
 
 
 
Figure 4.31: LC-MS analysis of oxaloacetate generated by PEPC which is further 
derivatized with PFBHA (137) when different isotopologues of L-tryptophan are used as 
substrates for NosL reaction. A) MS of derivatized compound 138 is [M-H]- = 326.0 Da 
when unlabeled L-tryptophan (13) is used as substrate. B) MS of derivatized compound 
138a is [M-H]- = 327.0 Da when [1,2,3-13C3, 2-amino-15N1]-L-tryptophan (13d) is used 
as substrate. C) MS of derivatized compound 138a is [M-H]- = 327.0 Da when [1-13C1]-
L-tryptophan (13e) is used as substrate. 
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To further confirm the formation of cyanide (82), its derivatization was carried 
out using 122 and 123 as shown in Figure 4.22A. MS of the derivatized product 124 was 
analyzed to investigate the incorporation of C2 and C2 amino fragments from 
isotopologues of L-tryptophan as shown in Figure 4.32. 
 
 
 
 
 
 
 
Figure 4.32: LC-MS analysis of derivatized cyanide when different isotopologues of L-
tryptophan (13) are used as substrates for NosL reaction. A) MS of derivatized 
compound 124 is [M-H]- = 299 Da when unlabeled L-tryptophan (13) is used as 
substrate. B) MS of derivatized compound 124a is [M-H]- = 300 Da when [15N2]-L-
tryptophan (13f) is used as substrate. C) MS of derivatized compound 124b is [M-H]- = 
301 Da when [1,2,3-13C3, 2-amino-15N1]-L-tryptophan (13d) is used as substrate. 
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After cyanide (82) was observed as a product of the native NosL catalyzed 
reaction with L-tryptophan (13), we investigated its formation in the previously 
described variants of NosL. Derivatization of cyanide was carried out using 122 and 123 
as shown in Figure 4.22A for the different variants of NosL. As shown in Figure 4.33, 
the fluorescence (Ex = 418 nm, Em = 454 nm) of the derivatized product 124 was 
observed on HPLC for NosL WT, Y90F, Y90A, C200A and S340A. However, cyanide 
was not observed with NosL R323K. The ratio of 3-methylindole (92) to cyanide (82) in 
NosL WT and its variants is close to 1:0.9. This demonstrates that cyanide (82) is the 
major byproduct of the NosL catalyzed reaction with L-tryptophan (13). 
 
 
 
  
Figure 4.33: Fluorescence detection of cyanide (82) formed during the reaction of NosL 
variants with L-tryptophan (13). Quantitative cyanide was detected in all variants tested 
except R323K. 
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4.4.11 Revised mechanistic proposal of the NosL catalyzed reaction 
The results mentioned in this section can be integrated into the mechanistic 
proposal for the NosL-catalyzed reaction with L-tryptophan (1) as shown in Figure 4.34. 
In this revised mechanism, the initially formed amine radical (14) undergoes a β-scission 
reaction to form 107 and the formyl radical (114) which then adds to the C2' of the 
indole to form 139. Loss of H2CN+ by a second β-scission reaction gives 140 which can 
also be described as an aryl radical anion 140'. Protonation of this radical by the strongly 
acidic H2CN+ followed by electron transfer back to the [4Fe-4S]+2 cluster gives the 
cation 142. This can either lose CO2 or a proton to give the experimentally observed 
reaction products 15 and 92 respectively. Alternatively loss of a formyl radical from 141 
could also generate 92. 
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Figure 4.34: Revised mechanistic proposal of the NosL catalyzed reaction integrating 
all the data mentioned in this section. 
 
 
 
4.5 Conclusion 
 In this section, we described a set of experiments using substrate analogs, 
mutants and isotopes of L-tryptophan (13) to probe the mechanism of NosL. We provide 
biochemical evidence in support of the structural studies showing that the 5′-
deoxyadenosyl radical (6, Ado) abstracts a hydrogen atom from the amino group of L-
tryptophan (13). We further demonstrated that D-tryptophan (104) is a substrate for NosL 
but shows relaxed regio control of the first β-scission reaction. Mutagenesis studies 
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confirm that Arg323 is important for controlling the regiochemistry of the β-scission 
reaction. Based on the early studies, a mechanism involving Cα-Cβ bond scission after 
the H-atom abstraction from L-tryptophan (13) is proposed. 
 With L-tryptophan thiocarboxylate (115), we provide evidence that the Cα-C(O) 
cleavage is the next step after the H-atom abstraction. Detection and characterization of 
aldehyde 108 in NosL WT and its variants also supports the Cα-C(O) cleavage instead of 
previously proposed β-bond scission involving the Cα-Cβ bond. Use of 2'-chloro-L-
tryptophan (119) or 2'-bromo-L-tryptophan (121) as substrates lead to the exclusive 
formation of 3-methylindole-2-carboxylic acid (15) and cyanide (82). Further 
investigation revealed that cyanide (82) is also a byproduct of the NosL catalyzed 
reaction with L-tryptophan (13).   
The revised mechanistic proposal is consistent with the EPR spectroscopy that 
provides evidence for the formation of 139.90 It is also consistent with the NosL reaction 
with L-tryptophan thiocarboxylate (115), which blocks the formation of 139 and 
demonstrates that the formation of 3-methylindole (92) can only occur after addition of 
the formyl radical to the indole.  Finally, it is consistent with the exclusive formation of 
3-methylindole-2-carboxylic acid (15) [no 3-methylindole (92) detected] as the sole 
product when 2'-chloro-L-tryptophan (119) is used as the substrate. The identification of 
cyanide (82) as a major NosL byproduct has important mechanistic implications and 
connects NosL chemistry with that of HydG – the radical SAM enzyme that forms 
cyanide (82) and carbon monoxide (83) from tyrosine during the biosynthesis of the 
metallo cluster of the [FeFe] hydrogenase (Figure 4.2B).91-93  
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4.6 Experimental procedures 
Materials: All chemicals were purchased from Sigma-Aldrich (now 
MilliporeSigma) unless specified otherwise. LB medium (Lennox formulation) was from 
EMD Millipore. Kanamycin was from Teknova and IPTG was obtained from Lab 
scientific Inc. Chloramphenicol was from Fisher Scientific. HPLC and LC-MS solvents 
were purchased from EMD and were used without further purification. Histrap column 
(5 ml) was obtained from GE healthcare. Econo-Pack 10DG and Bio-spin 6 desalting 
columns were purchased from Bio-Rad Laboratories. D2O, [13C3-15N1]-L-serine, [1-
13C1]-L-serine and 15N2-L-tryptophan were purchased from Cambridge Isotope 
Laboratories Inc. Large cultures were grown and overexpressed in 2.5 L baffled ultra 
yield flasks and sealed with AirOtop seals, both of which were from Thomson 
Instrument Company. E.coli containing plasmid of tryptophan synthase (pSTB7) was 
ordered from ATCC. Phosphoenolpyruvate carboxylase (PEPC) was purchased from 
ICN Biomedicals Inc. (now MP Biomedicals). Other enzymes like L-amino acid oxidase 
from Crotalus adamanteus, D-amino acid oxidase, α-chymotrypsin and amano acylase 
were obtained from Sigma-Aldrich. 2'-methyl-D,L-tryptophan (130a) was obtained from 
Chem-Impex International Inc. 
 
Overexpression and purification of NosL and its mutants: Gene of nosl from 
Streptomyces actuosus was cloned into pTHT vector (derivative of pET28b vector with 
TEV protease cleavage site after N-terminal His-tag). NosL was co-expressed with a 
plasmid encoding the suf operon in E.coli BL21(DE3) for in vivo assembly of the [4Fe-
4S] cluster. A starter culture was grown overnight in LB media containing kanamycin 
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(40 μg/ml) and chloramphenicol (25 μg/ml). 60 ml of this culture was added to 6L LB 
media (4x1.5L flasks) with antibiotics. The flasks were sealed with AirOtop and grown 
at 37°C with shaking (180 rpm) till OD600~0.6. The flasks were then incubated at 4 °C 
for ~1 hr without shaking. Each flask (1.5L) was supplemented with 120 mg ferrous 
ammonium sulfate and 120 mg cysteine. Cultures were then induced with 200 μM IPTG 
followed by incubation at 15 °C for ~16 hr with shaking (110 rpm). The cells were 
harvested by centrifugation and stored in liquid nitrogen until further use. Typical yields 
were 13-15 gm of cell pellet (wet weight) from 6L cell culture.  
All steps for NosL purification were carried out in an anaerobic chamber (COY 
laboratories). Cell pellets were thawed and resuspended in 60-70 ml of lysis buffer (100 
mM Tris-HCl, pH 7.5) at room temperature in the presence of lysozyme (8-10 mg) and 
benzonase (1000 units).  The suspension was stirred for ~1.5 hr on an ice-bath and 
further sonicated to lyse the cells. Cell debris was removed by centrifugation and the 
lysate was loaded onto a Histrap column pre-equilibrated with lysis buffer. The column 
was washed with 10 column volumes of wash buffer (100 mM Tris-HCl, 30 mM 
imidazole, 300 mM NaCl, pH 7.5). The protein was then eluted from the histrap column 
with elution buffer (100 mM Tris-HCl, 250 mM imidazole, 300 mM NaCl, pH 7.5). The 
dark colored fractions were pooled and buffer exchanged to 50 mM potassium 
phosphate, 10% glycerol, pH7.5 using an Econo-Pac 10DG desalting column. The 
purified enzyme was stored submerged in liquid nitrogen until further use.  
Protein concentration was measured by the absorbance at 280 nm (A280) with an 
extinction coefficient calculated using the ProtParam tool of the ExPASy proteomics 
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server. Typical yields were ~35 mg of enzyme per liter of cell culture. Iron content was 
determined using ferene assay while sulfide content was determined using methylene 
blue assay (methods previously described). Iron content of the purified enzyme was 
4.2+0.2 and the sulfide content was 3.7+0.1. All mutants of NosL were also purified 
using the above-described protocol. 
 
Overexpression and purification of FlavodoxinA/Flavodoxin reductase: The 
following protocol was used for both E.coli flavodoxin A (FldA) and flavodoxin 
reductase (FldR). Respective plasmids were transformed into E.coli BL21(DE3) cells. A 
starter culture was grown overnight in LB media containing kanamycin (40 μg/ml). 30 
ml of this overnight culture was added to 3L LB media (2x1.5L flasks) with kanamycin. 
The flasks were sealed with AirOtop and grown at 37 °C with shaking (210 rpm) till 
OD600~0.6. The flasks were then incubated at 4 °C for ~30 min without shaking. 
Cultures were then induced with 500 μM IPTG followed by incubation at 30 °C for ~6 
hr with shaking (180rpm). The cells were then harvested by centrifugation and stored at -
80 °C until further use.  
Protein purification was carried out under aerobic conditions. Cells were 
resuspended in 40 ml of lysis buffer (50 mM Tris-HCl, 10 mM imidazole, 150 mM 
NaCl, pH 7.5). This suspension was sonicated and centrifuged to separate debris. Cell 
lysate was loaded on a Histrap column pre-equilibrated with lysis buffer.  The column 
was washed with 100 ml of washing buffer (50 mM Tris-HCl, 20 mM imidazole, 150 
mM NaCl, pH 7.5) including 50 μM flavin (FMN for FldA and FAD for FldR). Elution 
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was carried out with elution buffer (50 mM Tris-HCl, 250 mM imidazole, 150 mM 
NaCl, pH 7.5). The protein fractions were concentrated and buffer exchanged with an 
Econo-Pac 10DG desalting column into 100 mM potassium phosphate, 150 mM NaCl, 
10% glycerol, 1 mM DTT, pH 7.5 under anaerobic conditions. The purified proteins 
were stored at -80°C until further use. 
 
Enzymatic reaction conditions for NosL: All NosL enzymatic reactions were 
carried out in an anaerobic chamber containing 95% nitrogen and 5% hydrogen. Typical 
enzymatic reaction was performed in 100 mM phosphate buffer, pH7.5 containing NosL 
(75-150 μM), dithionite (600 μM), L-tryptophan / substrate analog (400 μM - 500 μM) 
and SAM (600 μM).  
When assays were performed in the presence of the flavodoxin system, NosL 
was desalted using Bio-spin 6 columns (Bio-rad) into 100 mM phosphate buffer, pH 7.5. 
The components of the enzymatic reaction were NosL (75-100 μM), FldA (60 μM), 
FldR (40 μM), NADPH (750 μM), L-tryptophan / substrate analog (500 μM) and SAM 
(600 μM). The enzymatic reactions were incubated at room temperature for 2-3 hr. The 
enzymes were removed either by ultrafiltration using 10 kda cut-off filters (VWR) or by 
5-10% TFA (final conc.) and further analyzed by HPLC and LC-MS. 
For NMR analysis of enzymatic reactions, NosL was desalted using a Bio-spin 6 
column (Bio-Rad) into 100 mM phosphate buffer, pH 7.5 (to remove glycerol from the 
storage buffer). The components of the enzymatic reaction were NosL (75-100 μM), 
dithionite (750 μM), labeled L-tryptophan (400 μM) and SAM (600 μM). The enzymatic 
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reactions were transferred to NMR tubes and incubated in anaerobic chamber at room 
temperature for 2 hr.  
 
Overexpression of tryptophan synthase and chemo-enzymatic synthesis of L-
tryptophan isotopologues: Stock of E.coli BL21(DE3) cells containing plasmid of 
tryptophan synthase (pSTB7) was grown overnight in 20 ml LB media supplemented 
with 100 μg/ml	of	ampicillin.	15	ml	of	this	overnight	culture	was	used	to	inoculate	1.5L	media	containing	100 μg/ml	of	ampicillin.	The	cells	were	grown	at	37	°C	at	200	rpm	 for	24	hr.	The	 cells	were	harvested	by	 centrifuging	at	9000	 rpm	 for	10	min.	The	cells	were	divided	in	three	falcon	tubes	with	3.5	gm	wet	cells	in	each	falcon	and	stored	at	-80°C	until	further	use.		To	obtain	the	lysate,	cells	from	one	falcon	tube	were	suspended	in	35	ml	of	lysis	 buffer	 (50	 mM	 KH2PO4,	 pH7.6).	 2	 mg	 of	 pyridoxal	 5’-phosphate	 (PLP)	 was	added	 to	 it	 and	 4	 cycles	 of	 sonication	were	 performed	 (30	 sec,	 50%	 cycle,	 65%	power)	at	 the	 interval	of	10	min.	The	 lysate	was	centrifuged	at	18,000rpm	for	20	min	 at	 4	 °C	 and	 filtered	with	 0.22	 μm filters to remove cell debris. The lysate was 
stored in 4	°C	for	up	to	one	month	and	was	used	whenever	required	in	this	period.		To	synthesize	 the	 isotopologues	of	L-tryptophan	(13),	10	mg	of	 indole	and	12	 mg	 of	 respective	 isotopologues	 of	 L-serine	 were	 dissolved	 in	 12	 ml	 of	 lysis	buffer.	0.5	mg	of	PLP	was	added	to	this	solution	followed	by	addition	of	3	ml	lysate.	The	reaction	was	incubated	at	37	°C	at	200	rpm	for	3-4	hr.	Proteins were removed by 
heat denaturing at 75 °C	 for	 20	min	 followed	 by ultrafiltration using 10 kda cut-off 
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filters (VWR). Molecules were purified on HPLC using semi-prep column. Yield 5-8 mg 
product. 
 
Derivatization of Cyanide:87 A 1 ml stock solution for cyanide derivatization 
was prepared as follows: Add 200 μl	 of	 2,3-napthalenedicarboxaldehyde	 (122,	 10	mM	solution	in	methanol),	200	μl	of	taurine	(123,	50	mM	solution	in	water),	60	μl	of	7M	ammonia	in	methanol,	200	μl	of	methanol	and	140	μl	of	water.	Take	80	μl	of	this	stock	solution	in	an	Eppendorf	tube	and	add	20	μl	of	cyanide	(82)	standard	or	enzymatic	reaction	sample.	 Incubate	at	room	temp	for	15-30	min	and	quench	the	reaction	by	adding	100	μl	of	water.	Inject	10	μl	of	this	derivatized	sample	on	HPLC	and/or	LC-MS. 
 
Phosphoenolpyruvate carboxylase (PEPC) mediated derivatization of CO2:94 
All steps were performed in anaerobic chamber. Prepare all stock solutions in 100 mM 
KPi buffer, pH 7.5. Dissolve 1 mg of PEPC (activity 1.77 units/mg) in 200 μl of buffer, 
10 mM phosphoenolpyruvate (PEP) solution in buffer, 10 mM MgCl2 solution in buffer. 
To derivatize CO2 generated during the NosL catalyzed reaction, include 15 μl of PEPC, 
1 mM of PEP and 1 mM of MgCl2 while setting up NosL assay. The derivatize the 
oxaloacetate for LC-MS analysis, filter the enzymatic reaction using 10 kda cut-off 
filters (VWR) and add 5 mM o-(2,3,4,5,6-pentafluorobenzyl)-hydroxylamine.HCl 
(PFBHA) and heat at 60	°C	for	20	min. 
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HPLC parameters: An Agilent 1260 HPLC equipped with a quaternary pump 
was used. The system included a diode array UV-Vis detector and eluted compounds 
were detected by absorbance at 254 nm, 260 nm, 280 nm, 288 nm, 320 nm, 340 nm and 
475 nm. The parameters for the fluorescence detector were: excitation at 270 nm and 
emission at 352 nm (to detect indole based products) or excitation at 418 nm and 
emission at 454 nm (to detect derivatized cyanide 124). For analytical purposes, HPLC 
analysis was performed on a ZORBAX Eclipse XDB-C18 column (15 cm x 4.6 mm, 5 μm particles, Agilent Technologies, flow rate = 1 ml/min). Purification of the isotopes of 
L-tryptophan or its analogs, was carried out on semi-prep column from Supelcosil LC-18 
(25 cm x 10 mm, 5 μm particles, Supelco, flow rate 2 ml/min). Typical injection 
volumes were in the range of 10-80μl. Data was processed using ChemStation ver. 
B.04.01 SP1 (Agilent technologies). 
 
HPLC conditions:  
A- Water 
B- 100 mM Potassium phosphate buffer, pH 6.6 / 10 mM Ammonium acetate, pH 6.6 
C- Methanol 
 
HPLC method: (Flow rate 1 ml/min) 
0 min – 100% B, 5 min – 100% B, 14 min – 7% A 70% B 23% C, 25 min – 25% A 0% 
B 75% C, 28 min - 25% A 0% B 75% C, 32 min - 100% B, 36 min - 100% B. 
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LC-MS parameters: LC-ESI-TOF-MS was performed using an Agilent 1260 
HPLC system equipped with a binary pump and a 1200 series diode array detector 
followed by a MicroToF-Q II mass spectrometer (Bruker Daltonics) using an ESI source 
either in negative mode or positive mode. The samples were run either on LC-18-T 
column (15 cm x 3 mm, 3	μm particles, Supelco, flow rate 0.4 ml/min) or Poroshell 120 
EC-C18 (10 cm x 3 mm, 2.7	 μm particles, Agilent, flow rate 0.4 ml/min). Typical 
injection volumes were in the range of 10-80 μl. The data was processed using 
DataAnalysis 4.0 SP1 (Bruker Daltonics). 
 
LC conditions: (Flow rate 0.4 ml/min) 
A- 5 mM Ammonium acetate buffer, pH 6.6 
B- 75% Methanol and 25% Water. 
 
LC method: (for negative mode on MS) 
0 min – 100% A, 7 min – 100% A, 10 min – 80% A 20% B, 27 min – 100% B, 29 min – 
100% B, 30 min – 100% A, 40 min – 100% A. 
 
LC method: (for positive mode on MS) 
0 min – 100% A, 2 min – 100% A, 4 min – 80% A 20% B, 27 min – 100% B, 29 min – 
100% B, 30 min – 100% A, 40 min – 100% A. 
 
MS parameters: (for all LC-MS experiments) 
Capillary, -4500 V; capillary offset, -500 V; nebulizer gas, 3.0 bar; dry gas, 10 L/min; 
dry gas temperature, 200 °C; funnel 1 RF, 250.0 Vpp; funnel 2 RF, 300.0 Vpp; ISCID, 
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0.0 eV; hexapole RF, 200 Vpp; quadrapole ion energy, 3.0 eV; collision cell, collision 
energy, 8.0 eV; collision RF, 150.0 Vpp, transfer time, 80.0 μs; prepulse storage, 5.0 μs. 
 
NMR analysis: 
NMR spectra of all the synthetic samples and enzymatic reactions were recorded on a 
Bruker Avance III 400 MHz instrument. 
 
Purity of substrate analogs: During our investigation, we found that NosL 
accepts D-stereoisomers of tryptophan and its analogs as substrates and generates 
different β-scission products. Thus, utmost care was taken to ensure L-stereoisomer of 
analogs is used wherever mentioned in this section. After synthesis, all analogs were 
purified on HPLC using a semi-prep column. The stereo-specificity of these analogs was 
tested by treating them with L-amino acid oxidase (LAAO) and D-amino acid oxidase 
(DAAO).95 Complete consumption of each substrate analog when treated with L-amino 
acid oxidase confirmed that only L-stereoisomer of each compound was present (Figure 
4.35). Additionally, no activity was detected with D-amino acid oxidase with any 
analog.96 
 
 
 
 
Figure 4.35: L-amino acid oxidase (LAAO) was used to test the stereospecific purity of 
substrate analogs. This enzyme specifically acts on the L-stereoisomer of amino acids. 
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Synthesis of L-tryptophan thiocarboxylate (115):97  
Step 1: In a dry round bottom flask, dissolve 2 mmol of 2,5-dioxopyrrolidin-1-yl 
(((9H-fluoren-9-yl)methoxy)carbonyl)-L-tryptophanate (143, from Chem-Impex 
International Inc.) and 2 mmol of sodium hydrosulfide in dry ethanol and stir at room 
temperature for 8 h. Solvent was removed on rotovap, residue dissolved in 50 ml of 
water, acidified with 5% HCl up to pH = 3 and extracted twice with 30 ml of ethyl 
acetate. Combined ethyl acetate solutions were dried with anhydrous Na2SO4, separated 
and concentrated under reduced pressure to obtain crude product, which was additionally 
purified by column chromatography on silica gel with hexanes/ethyl acetate mixture 4:1-
2:1, to give sticky oil 50-60% yield of 144. 
Step 2: Solution of 200 mg of (S)-2-((((9H-Fluoren-9-
yl)methoxy)carbonyl)amino)-3-(1H-indol-3-yl)propanethioic S-acid (144) in 1 ml of 
20% pyrrolidine in DMF was stirred at room temperature for 4 hr. The solvent was the 
removed under reduced pressure and the residue was subjected to flash chromatography 
purification using silica gel. Elution using ethyl acetate and methanol gave 50 mg of 
white solid (115, 50%). The compound was further purified using HPLC. 
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Figure 4.36: Synthesis of L-tryptophan thiocarboxylate (115). A) Synthetic scheme. B) 
1H-NMR of the product L-tryptophan thiocarboxylate (115). C) 13C-NMR of the product 
115. 
 
 
 
Synthesis of 2'-chloro-L-tryptophan (119):  
 2'-Chloro-L-tryptophan (119) was synthesized by a previously reported protocol 
with minor variations.98 In a dry round bottom flask, 5.1 mmol of L-tryptophan methyl 
ester.HCl (145, 1.3 gm) was dissolved in 50 ml acetic acid and 15 ml formic acid. To 
this solution 5.2 mmol of N-chlorosuccinimide (146, 700 mg) was added. The reaction 
mixture was stirred at room temperature for 30 min and solvents were removed using 
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rotovap. The product 147 was purified by flash chromatography (silica, 
dichloromethane:methanol = 95:5). Isolated yield was ~50%. Since the C2-chloro group 
is susceptible to acid/base hydrolysis, de-protection of the ester group was performed 
using α-chymotrypsin.  500 mg of 147 was dissolved in 10 ml of dioxane in a round 
bottom flask. A separate solution containing 50 mg of α-chymotrypsin (Type II, from 
bovine pancreas), 45 ml of water, 2 ml of 1M NaHCO3 and 10 ml dioxane, was added to 
this solution in a round bottom flask. The reaction mixture was stirred for ~6 hr at room 
temperature which was further frozen using Liq. N2 and lyophilized overnight. The 
residual mixture was suspended in methanol and filtered through celite. The residue was 
washed with methanol and the solvent was removed using rotovap to obtain 119. 
Isolated yield was ~90%. NMR was recorded in CD3OD. Compound 119 was further 
purified using HPLC.  
For synthesis of 2'-bromo-L-tryptophan (121), procedure described above was 
adopted with L-tryptophan methyl ester.HBr and N-bromosuccinimide. 
 
 
 
 
 
Figure 4.37: Synthesis of 2'-chloro-L-tryptophan (119). A) Synthetic route. B) 1H-NMR 
of the product 2'-chloro-L-tryptophan (119). C) 13C-NMR of the product 119. 
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Figure 4.37 continued. 
 
 
 
Synthesis of 2'-methyl-L-tryptophan (130) 
 2'-methyl-D,L-tryptophan (130a) was obtained commercially from Chem-Impex 
international Inc. This compound was acetylated using acetic anhydride by heating at 60 °C for 30 min in acetic acid (Figure 4.38). The solvent was removed using rotovap and 
solid was dissolved in KPi buffer, pH 8. Amano acylase was added to this solution and it 
was stirred for 2 hr at 50 °C. Stereospecific 2'-methyl-L-tryptophan (130) was obtained 
by HPLC purification.  
B) 
C) 
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Figure 4.38: Scheme depicting synthesis of 2'-methyl-L-tryptophan (130) from 2'-
methyl-D,L- tryptophan (130a). 
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5. TRYPTOPHAN LYASE (NOSL): A CORNUCOPIA OF 5′-DEOXYADENOSYL 
RADICAL MEDIATED TRANSFORMATIONS*  
 
5.1 The reactive 5′-deoxyadenosyl radical (6) 
 In the biological world, complex transformations often involve radical 
intermediates. Enzymes from different families like the adenosyl cobalamin dependent 
enzymes,99 cytochrome P450 dependent enzymes,66 non-heme iron dependent 
enzymes100 and radical S-adenosyl-L-methionine (SAM)12 dependent enzymes catalyze 
these radical mediated reactions. Amongst these enzyme families, adenosyl cobalamin 
dependent enzymes and radical SAM enzymes utilize the 5′-deoxyadenosyl radical (6) as 
a potent oxidant. The bond dissociation energy of the C5'-H in 5′-deoxyadenosine is 
~433 kJ/mol, making it the most reactive organic radical in living organisms.101 To avoid 
inactivating the enzyme with this highly reactive radical, its reactivity must be tightly 
controlled at the active site. It is generally assumed that one of the control mechanisms 
involves formation of the 5′-deoxyadenosyl radical in close proximity to the abstracted 
hydrogen atom.102 In this section we describe studies with enzyme and substrate analogs 
that reveal unanticipated mobility of the radicals formed at the active site of NosL. 
  
*Reprinted in parts with permission from “Tryptophan Lyase (NosL): Mechanistic 
Insights from Substrate Analogues and Mutagenesis” by Bhandari, D. M., Xu, H., 
Nicolet, Y., Fontecilla-Camps, J. C., & Begley, T. P. Biochemistry, 2015, 54(31), 4767-
4769. Copyright 2015 American Chemical Society and from “Tryptophan Lyase (NosL): 
A Cornucopia of 5′-Deoxyadenosyl Radical Mediated Transformations” by Bhandari, D. 
M., Fedoseyenko, D., & Begley, T. P. J. Am. Chem. Soc. 2016, 138 (50), 16184-16187. 
Copyright 2016 American Chemical Society. 
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5.2 Results and discussion 
5.2.1 Reaction of NosL with N-methyl-L-tryptophan (149) 
NosL catalyzes the demethylation of Nα-methyl-L-tryptophan (149), followed by 
the conversion of L-tryptophan (13) to 3-methyl-2-indolic acid (15) and 3-methylindole 
(92) (Figure 5.1).  
 
 
 
 
 
 
 
 
Figure 5.1: Analysis of the NosL reaction with Nα-methyl-L-tryptophan (149). A) 
Scheme showing demethylation of 149 catalyzed by NosL. B) HPLC analysis of the 
time-course showed formation of a new signal at 15.5 min, which was consumed as the 
duration of the enzymatic reaction was increased. C) LC-MS analysis showing EIC [M-
H]- = 203.0 Da confirming the identity of the new signal as L-tryptophan (13) (only 
observed in the ‘full reaction’). D) HPLC analysis showing formation of 3-methylindole 
(92) observed only in the ‘full reaction’ sample. E) LC-MS analysis of the enzymatic 
reaction performed with the FldA/R system showing EIC of [M-H]- = 174.0 Da 
confirming formation of 3-methyl-2-indolic acid (15) in the ‘full rxn’ sample. F) MS of 
15 generated during enzymatic reaction. 
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Figure 5.1 continued. 
 
 
 
To study the mechanism of demethylation, the enzymatic reaction was performed 
in 95% D2O buffer. However, low deuterium incorporation was observed in 5′-
deoxyadenosine suggesting that the H-atom abstraction position is not the amino group.  
When the reaction was carried out using Nα-methyl-d3-L-tryptophan (149a), deuterium 
transfer from the methyl group to 5′-deoxyadenosine (93a) was observed (Figure 5.2). 
This demonstrates that the 5′-deoxyadenosyl radical (6) abstracts a H-atom from the 
methyl group instead of the amino group as previously seen in the native reaction.  
 
 
 
 
 
Figure 5.2: MS of 5′-deoxyadenosine (93) generated. A) 5′-Deoxyadenosine (93) 
generated in the ‘full reaction’ with Nα-methyl-L-tryptophan (149). B) 5′-
Deoxyadenosine (93a) generated in the ‘full reaction’ with Nα-methyl-d3-L-tryptophan 
(149a). 
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Figure 5.2 continued. 
 
 
 
A mechanistic proposal for the NosL-dependent demethylation reaction of 149 is 
shown in Figure 5.3. The 5′-deoxyadenosyl radical (6) abstracts a H-atom from the 
methyl group of 149 generating 150. Intermediate 150 loses an electron to the [4Fe-4S] 
generating 151 which is be rapidly hydrolyzed to L-tryptophan (13).  
 
 
 
 
Figure 5.3: Mechanistic proposal for the NosL catalyzed demethylation of Nα-methyl-L-
tryptophan (149). 
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5.2.2 Reaction of NosL with N-cyclopropyltryptophan (152) 
 Nα-cyclopropyltryptophan (152) was also investigated as a probe for the nitrogen 
centered radical, but this molecule was not a substrate for the WT enzyme. Reasoning 
that this might be due to the size of the cyclopropyl ring, the active site was enlarged by 
construction of the Y90A variant with the goal of using this analog to determine the 
relative rate of the β-bond scission of the amino radical. HPLC analysis of the NosL 
Y90A-catalyzed reaction with 152 revealed the formation of indole-3-pyruvic acid (111, 
Figure 5.4).  
 
 
 
 
 
Figure 5.4: HPLC analysis of the NosL Y90A reaction with Nα-cyclopropyltryptophan 
(152). A) HPLC analysis at 280 nm indicates formation of a new signal in the ‘Full Rxn’ 
sample. B) LC-MS analysis showing EIC [M-H]- = 202.0 Da indicating the formation of 
indole-3-pyruvic acid (111) in the ‘Full Rxn’ sample. C) MS of indole-3-pyruvic acid 
(111) generated during the enzymatic reaction. D) LC-MS analysis showing EIC [M-H]- 
= 202.0 Da and co-injection with the authentic standard of 111 confirming its formation. 
E) Reaction scheme showing the derivatization of cyclopropylamine (153) with NBD-F 
(154). F) LC-MS analysis after NBD-F treatment showing EIC [M-H]- = 219.0 Da and 
221 Da suggesting the formation of the adduct 155 in the ‘Full Rxn’ sample. G) MS of 
155 generated after NBD-F derivatization of the enzymatic reaction. H) LC-MS analysis 
after NBD-F treatment showing EIC [M-H]- = 219.0 Da and co-injection with NBD-F 
derivatized authentic standard of 153 confirming formation of 155. 
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Figure 5.4 continued. 
 
 
 
LC-MS analysis of the reaction mixture after treatment with 4-fluoro-7-
nitrobenzofurazan (NBD-F, 154)103 demonstrated formation of the cyclopropylamine-
NBD adduct (155) with no evidence for the anticipated cyclopropyl ring opening. 
 Additionally, deuterium incorporation into 5′-deoxyadenosine (93) was not 
observed when the reaction was carried out in 95% D2O buffer. These results suggested 
that the amino group is not the site of the initial H-atom abstraction. To identify the 
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position of H-atom abstraction from the substrate, we synthesized 152a deuterated at the 
Cα	position.	When this Cα-deuterated	152a isotopologue was used for the enzymatic 
reaction with NosL Y90A, analysis of the 5′-deoxyadenosine (93) generated during the 
enzymatic reaction showed incorporation of a single deuterium (Figure 5.5). 
 
 
 
 
 
 
 
Figure 5.5: Analysis of the 5'-deoxyadenosine (93) generated during the NosL reaction 
with 152. A) MS of 93 generated during the reaction of NosL Y90A with 152 in 95% 
D2O buffer. B) MS of 93 generated during the reaction of NosL Y90A with 152a. 
 
 
 
A mechanistic proposal consistent with these observations is shown in Figure 
5.6. H-atom abstraction from the Cα position of 152 gives 156. Amine deprotonation 
followed by electron transfer back to the cluster gives 158, which undergoes hydrolysis 
to give the observed products 111 and 153.  
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Figure 5.6: Mechanistic proposal for the NosL Y90A-catalyzed reaction of Nα-
cyclopropyltryptophan (152). 
 
 
 
This experiment completes the series shown in Figure 5.7 in which the active site 
5′-deoxyadenosyl radical (6) of NosL abstracts a hydrogen atom not only from the amine 
of the substrate (13), but also from the methyl group of 149 and Cα of 152.   
 
 
 
 
Figure 5.7: The 5′-deoxyadenosyl radical (6) in the active site of NosL shows relaxed 
regiospecificity with substrate analogs 149 and 152. 
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5.2.3 Reaction of NosL with D,L-indole-3-lactic acid (159) 
 NosL is the first example in radical SAM enzymology where a H-atom 
abstraction from the amino-group has been unequivocally demonstrated. The N-H bond 
dissociate energy (BDE) is ~425 kJ/mol while that of C5'-H in 5′-deoxyadenosine is 
~433 kJ/mol.101 We were interested in investigating if the 5′-deoxyadenosyl radical (6) is 
capable of abstracting a H-atom from the alcoholic O-H which has BDE of ~440 kJ/mol 
(phenolic O-H has BDE of ~360 kJ/mol making this H-atom abstraction highly 
favorable). To experimentally test this possibility, the NosL reaction was performed 
using D,L-indole-3-lactic acid (159) as substrate. As shown in Figure 5.8, 159 acts as a 
substrate for NosL and generates 111 and 108. This demonstrates that the 5′-
deoxyadenosyl radical (6) can abstract a H-atom from the alcoholic O-H group.  
 
 
  
 
 
 
 
 
Figure 5.8: Analysis of the NosL enzymatic reaction with D,L-indole-3-lactic acid (159). 
A) HPLC analysis at 280 nm showed consumption of substrate only in the ‘full reaction’ 
sample. B) HPLC analysis at 280 nm showing two new signals corresponding to 111 and 
108. C) LC-MS analysis showing EIC [M-H]- = 202.0 Da confirming formation of 111 
in the ‘full reaction’ sample. D) MS of 111 generated. E) LC-MS analysis showing EIC 
[M-H]- = 158 Da indicating formation of 108 in the ‘full reaction’ sample. F) MS of 108 
generated during the NosL-catalyzed reaction. 
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Figure 5.8 continued. 
 
 
 
 To further confirm formation of indole-3-acetaldehyde (108), the ‘full reaction’ 
sample was reduced with NaBH4 generating tryptophol (113) (Figure 5.9). This sample 
was then co-injected with the authentic standard of 113 demonstrating that 108 is 
generated when the NosL reaction is performed in the presence of D,L-indole-3-lactic 
acid (159). 
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Figure 5.9: Analysis of tryptophol (113) generated by NaBH4 reduction of indole-3-
acetaldehyde (108) which is produced during the NosL reaction with D,L-indole-3-lactic 
acid (159). A) LC-MS analysis showing EIC [M-H]- = 160.0 Da for the NaBH4 reduced 
sample of the ‘full reaction’. The sample was co-injected with authentic standard of 113 
confirming the identity of the new signal. B) MS of 113 generated after treatment of the 
‘Full reaction’ sample with NaBH4. 
 
 
 
 A mechanistic proposal for the NosL catalyzed conversion of D,L-indole-3-lactic 
acid (159) to indole-3-pyruvic acid (111) and indole-3-acetaldehyde (108) is outlined in 
Figure 5.10. The 5′-deoxyadnosyl radical (6) abstracts a H-atom from the alcoholic O-H 
of 159 generating 160. Intermediate 160 can undergo decarboxylation followed by the 
loss of electron to generate 108 or it can be deprotonated at Cα and the subsequent loss 
of electron will form 111. 
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Figure 5.10: Mechanistic proposal for the NosL-catalyzed conversion of 159 into 
indole-3-pyruvic acid (111) and indole-3-acetaldehyde (108).  
 
 
 
5.2.4 Reaction of NosL with methylene analog of tryptophan104-105 
 The MqnE-catalyzed formation of aminofutalosine (164) in menaquinone 
biosynthesis is a recently discovered exception to the general rule that H-atom 
abstraction is the first step in all reactions catalyzed by radical SAM enzymes (Figure 
5.11).106 In this system, the substrate radical is formed by addition of the 5′-
deoxyadenosyl radical (6) to the double bond of 163 to give a radical intermediate that 
then undergoes rearrangement to give 164.  
 
 
 
 
Figure 5.11: Addition of the 5′-deoxyadenosyl radical to the alkene group. A) MqnE-
catalyzed addition of the 5′-deoxyadenosyl radical to 163 leading to the formation of 
aminofutalosine (164). B) Methylene analog of tryptophan (165). 
NosL
Ado Ado-H
OH
N
H
O
O
O
N
H
O
O
O
N
H
O
O
- e
O
N
H
O
O
-CO2
O
N
H
- H+
O
N
H
- e
108
111
162
161160159
COOH
O COOH
MqnE HOOC
O N
NN
N
NH2
O
OHOH
CO2
163 164
SAM N
H
O
OH
165
A) B)
  136 
 The regiochemical tolerance of the 5′-deoxyadenosyl radical (6) at the active site 
of NosL suggested that NosL might catalyze a radical addition to the methylene analog 
of tryptophan (165).107 When 165 was treated with NosL, three new products were 
observed by LC-MS analysis (Figure 5.12B). To reduce the unfavorable interaction 
between the methylene group in 165 and Arg323, we next investigated the reaction of 
165 with NosL R323K. This variant showed ~10-fold enhancement in the formation of 
all three adducts (Figure 5.12D). It was not possible to characterize the reaction products 
by NMR because of their instability during purification. 
 
 
 
 
 
 
  
 
 
Figure 5.12: Analysis of the NosL reaction with the methylene analog 165. A) LC-MS 
analysis showing EIC [M-H]- = 250.0 Da confirming the absence of 93 in the ‘Full Rxn’ 
sample with NosL WT. B) LC-MS analysis showing EIC [M-H]- = 451.1 Da suggesting 
the formation of three isomeric products corresponding to the mass of the adduct 
resulting from addition of the 5′-deoxyadenosyl radical to the 165 (one isomer shown). 
C) MS of the Peak 1 product generated in the  ‘Full Rxn’ sample. D) HPLC analysis at 
280 nm showing the enhanced formation of the three products when 165 is reacted with 
NosL R323K. E) LC-MS analysis showing EIC [M-H]- = 451.1 Da confirming that these 
three signals correspond to the mass of the adducts seen with NosL WT. F) MS of the 
Peak 1 product 167 generated in ‘Full Rxn’ sample with NosL R323K. 
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Figure 5.12 continued. 
 
 
 
The three products with the identical m/z values are consistent with the expected 
mass of adducts between the substrate 165 and the 5′-deoxyadenosyl radical (6) 
suggesting that the latter radical added to both carbons of the double bond of 165 (Figure 
5.13). This addition will be facially specific and determined by the active site structure. 
Quenching of 166 uses two different hydrogen atom donors and gives 167a, 167b as a 
mixture of two epimers (path a). Quenching of radical 168 will give 169 as a single 
isomer (path b).  
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Figure 5.13: Addition of the 5′-deoxyadenosyl radical (6) to the double bond of indole 
methyl acrylate 165 during the NosL catalyzed reaction. 
 
 
 
5.2.5 Reaction of NosL with indole-3-pyruvic acid (111) 
In search of a tryptophan analog that would give more stable products, indole-3-
pyruvic acid (111) was next tested using NosL R323K. HPLC analysis of the resulting 
reaction mixture indicated the absence of 5′-deoxyadenosine (93) and the formation of a 
new compound eluting at 24 min (Figure 5.14). LC-MS analysis of this product gave a 
mass that was consistent with 22, generated by 5′-deoxyadenosyl radical addition to the 
carbonyl followed by radical induced decarboxylation of 20 and electron transfer back to 
the cluster (Figure 5.14A).  
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Figure 5.14: Reaction of NosL R323K with indole-3-pyruvic acid (111). A) Mechanistic 
proposal for the formation of 172 by addition of the 5′-deoxyadenosyl radical (6) to 
indole-3-pyruvic acid (111). B) HPLC analysis at 280 nm of the NosL R323K reaction 
with 111 showing consumption of substrate and formation of a new product only in the 
‘Full Rxn’ sample. C) LC-MS analysis showing EIC [M-H]- = 407.1 Da suggesting the 
formation of an adduct 172. C) MS of the reaction product 172 in negative mode. 
 
 
 
The product 172 was stable and was purified by HPLC using 10 mM ammonium 
acetate as the elution buffer. The collected sample was lyophilized and dissolved in d6-
DMSO for NMR analysis (Figure 5.15).  
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Figure 5.15: Characterization of the product generated by the reaction of NosL R323K 
with indole-3-pyruvic acid (111). A) HPLC analysis at 260 nm showing the collection of 
the signal corresponding to the product 172. B) 1H-NMR of the collected product 172 in 
d6-DMSO. C) 13C-NMR of compound 172. D) 1H-13C HSQC-NMR of product 172. E) 
1H-1H COSY-NMR of product 172. F) DEPT-135 NMR spectrum of compound 172. 
CH2 are shown negative while CH and CH3 are positive. 
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Figure 5.15 continued.  
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Figure 5.15 continued.  
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5.2.6 Reaction of NosL Y90A in absence of a substrate 
 The Y90F and Y90A NosL variants, in the absence of L-tryptophan (13) or its 
analogs, catalyzed the conversion of SAM to a new product, as indicated by HPLC 
analysis (Figure 5.16). UV-Vis analysis indicated the presence of the adenosine 
chromophore. LC-MS analysis gave an [M-H]- = 282 Da consistent with structure 173. 
This was confirmed by derivatization with iodoacetamide (174), which resulted in a new 
species with [M-H]- = 339 Da consistent with 175. Low levels of compound 173 were 
also observed with NosL WT as well as when FldA/FldR system was used. 
 
 
 
 
 
 
 
 
 
Figure 5.16: Analysis of the formation of 5'-deoxy-5'-thioadenosine (173). A) HPLC 
analysis at 260 nm of the NosL Y90A reaction with L-tryptophan (13). A new SAM-
derived product is formed, in the absence of the amino acid substrate, that elutes at 20 
min. B) LC-MS analysis showing EIC [M-H]- = 282.0 Da suggesting that this compound 
is 173. C) MS of 173. D) Derivatization of 173 using iodoacetamide (174) generates 
adduct 175. E) LC-MS analysis showing EIC [M-H]- = 339.0 Da confirming formation 
of 175. The signal of EIC [M-H]- = 282.0 Da disappeared after iodoacetamide treatment. 
E) MS of derivatized 5'-deoxy-5'-thioadenosine (175). 
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Figure 5.16 continued. 
 
 
 
 A mechanistic proposal for the formation of 5′-deoxy-5′-thioadenosine (173) is 
shown in Figure 5.17 (path a). In this proposal, the 5′-deoxyadenosyl radical (6) reacts 
with one of the sulfurs in the oxidized cluster to form 6a, which decomposes to give 
173.108 In NosL, formation of 173 is observed in higher amounts in Y90A and Y90F 
mutants when compared to WT. This suggests that residues like Y90 in the active site 
might act as H-atom donors to the 5'-deoxyadenosyl radical (6) during the uncoupled 
reaction. Recently, interaction of 6 with [4Fe-4S] was demonstrated using EPR.109 
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Figure 5.17: Mechanistic proposal for the formation of 5′-deoxy-5′-thioadenosine (173) 
involving C-S bond formation with the [4Fe-4S] cluster. 
 
 
 
The iodoacetamide derivatized product 175 was purified by HPLC and its 
structure was confirmed by NMR analysis (Figure 5.18). 
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Figure 5.18: NMR characterization of the iodoacetamide derivative of 5'-deoxy-5'-
thioadenosine 175. A) HPLC analysis at 260 nm of the iodoacetamide derivatized NosL 
Y90A derived product. The signal that was collected is highlighted between the red and 
the green vertical lines. B) 1H-NMR of the collected product 175. C) 13C-NMR of 175. 
D) 1H-1H COSY-NMR of compound 175.  
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Figure 5.18 continued. 
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5.2.7 Reaction of NosL with L-tryptophanamide (176) 
Enzyme-generated radical intermediates are sequestered from the buffer and 
generally cannot be trapped by exogenous reagents such as spin traps or hydrogen atom 
donors. Dithionite is emerging as an exception to this and sulfinic acid products have 
been reported for the spore photoproduct lyase,110 Dph272 and DesII systems,111 
suggesting that 179 can diffuse into active sites and trap radical intermediates. This 
hypothesis was tested for the NosL catalyzed reaction. 
 LC-MS analysis of the NosL-catalyzed reaction of L-tryptophanamide (176) 
demonstrated the formation of a new product (Figure 5.19) having a mass consistent 
with sulfuramidite 180 resulting from the trapping of 176 by 179.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.19: NosL-catalyzed formation of sulfinic acids. A) Generation of the 
sulfuramidite 180 with L-tryptophanamide (176). B) LC-MS analysis showing EIC [M-
H]- = 266.0 Da suggesting that the new product is the sulfuramidite 180. C) MS of the 
sulfuramidite 180. 
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Similar adducts were observed with several other tryptophan analogs (N-methyl-
L-tryptophanamide, N-ethyl-L-tryptophanamide, L-tryptophan methyl ester, L-tryptophan 
ethyl ester methyl-D,L-indole-3-lactate, ethyl-D,L-indole-3-lactate). In addition, 5′-
deoxyadenosyl-5′-sulfinic acid (187) was observed in the absence of substrate and with 
enhanced levels in the presence of L-tryptophan ethyl ester. Summary of different 
dithionite adducts observed during investigation of the NosL catalyzed reaction are 
shown in Figure 5.20. 
 
 
 
 
Figure 5.20: Summary of the dithionite adducts observed during the NosL-catalyzed 
reaction with the corresponding substrate analogs. 
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5.3 Conclusion 
 In this section we explored the reactivity of 5′-deoxyadenosyl radical (6) with 
NosL. We have demonstrated that Nα-alkylated tryptophan analogs are substrates for 
NosL and that the alkyl group (R) can alter the regiochemistry of the initial hydrogen 
atom abstraction from the amino group (R=H) to the alkyl group (R=Methyl) or to the 
Cα (R=cyclopropyl). Additionally, we have also demonstrated that the 5′-deoxyadenosyl 
radical (6) can abstract a H-atom from alcoholic O-H group if it is present in its vicinity. 
We have also demonstrated that replacing the substrate amine with a ketone or an 
alkene changes the 5′-deoxyadenosyl radical chemistry from hydrogen atom abstraction 
to double bond addition and we propose that this strategy may be useful for the design of 
bisubstrate inhibitors of radical SAM enzymes. Such inhibitors would be of use for 
structural studies and as lead compounds for antibiotic development. 
Additionally, we have also demonstrated that the 5′-deoxyadenosyl radical (6) 
can add to one of the sulfurs in the [4Fe-4S] cluster. C-S bond formation leading to 173 
would result in enzyme inactivation and may be one of the contributing factors to the 
low turnover of enzymes in this superfamily. 
Various sulfuramidites were trapped when the NosL reaction was performed in 
presence of dithionite. This suggests that dithionite has potential for the trapping of 
intermediates at the active sites of most radical SAM enzymes. Preliminary experiments 
with other radical SAM enzymes like MoaA,112 BzaF,113 MqnC,114 and MqnE106 suggest 
that many of these findings will have some generality in radical SAM enzymology. 
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5.4 Experimental procedures 
Materials: All chemicals were purchased from Sigma-Aldrich unless specified 
otherwise. LB medium (Lennox formulation) was from EMD Millipore. Kanamycin was 
bought from Teknova and IPTG was obtained from Lab scientific Inc. Chloramphenicol 
was from Fisher Scientific. HPLC and LC-MS solvents were purchased from EMD and 
were used without further purification. Bradford reagent was purchased from 
ThermoFisher Scientific. Histrap column was obtained from GE healthcare. Econo-Pack 
10DG desalting columns were purchased from Bio-Rad. D2O was purchased from 
Cambridge Isotope Laboratories. Large cultures were grown and overexpressed in 2.5L 
baffled ultra yield flasks from Thomson Instrument Company. 
 
Overexpression and purification of NosL, mutants of NosL, FldA and FldR: 
Gene of nosl from Streptomyces actuosus was used for all the studies. The 
overexpression and purification of all enzymes were performed as previously described 
in section 4.6. 
 
Enzymatic reaction conditions for NosL: All enzymatic reactions of NosL and 
its mutants were carried out in an anaerobic chamber containing 95-97% nitrogen and 3-
5% hydrogen. A typical enzymatic reaction was performed in 100 mM phosphate buffer, 
pH7.5 containing NosL (75-150 µM), dithionite (750 µM), L-tryptophan / substrate 
analog (400-500 µM) and SAM (600 µM). When assays were performed in the presence 
of the flavodoxin system, NosL was desalted using a Bio-Spin 6 column (Bio-Rad) into 
100 mM phosphate buffer, pH 7.5. The components of the enzymatic reaction were 
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NosL (75-100 µM), FldA (60 µM), FldR (40 µM), NADPH (750 µM), L-tryptophan / 
substrate analogue (500 µM) and SAM (600 µM). The enzymatic reactions were 
incubated at room temperature for 2-3 h. Protein was removed by ultrafiltration using 10 
kda cut-off filters (VWR) and the reaction mixture was further analyzed by HPLC and 
LC-MS. 
 
HPLC and LC-MS parameters: These parameters were kept identical to the ones 
previously described in section 4.6. 
 
NMR analysis: NMR spectra of all the synthetic samples were recorded on 
Bruker Avance III 400 MHz instrument. NMR characterization of samples collected by 
HPLC was performed on Bruker Avance III 500 MHz instrument with H-C-N cryoprobe 
in 3 mm Wilmad labglass (328-PP-7) high precision NMR tubes. 
 
Synthesis of Nα-cyclopropyltryptophan (152): Substrate analog 152 was 
designed to probe the ring opening of cyclopropyl group after generation of a nitrogen-
centered radical during the NosL-catalyzed reaction. This compound was synthesized 
according to the scheme shown in Figure 5.21A. Briefly, in a dry round bottom flask, 51 
mg (0.25 mmol) of indole-3-pyruvic acid (111) was added to 8 ml dry methanol under 
an argon atmosphere. This was followed by addition of 70 µl (1 mmol) of 
cyclopropylamine (153) and 65 mg (1 mmol) of sodium cyanoborohydride. The reaction 
mixture was stirred under an inert atmosphere at room temperature for ~2 days. The 
precipitate of 152 was collected by vacuum filtration. Yield ~60 mg (98%). The 
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compound was characterized using NMR and LC-MS. For synthesis of Cα-deuterated 
isotope 152a, NaBD3CN was used for reduction instead of NaBH3CN described in the 
above discussed procedure. 
 
 
 
 
 
 
  
 
 
Figure 5.21: Synthesis of Nα-cyclopropyltryptophan (152). A) Synthetic scheme. B) 1H-
NMR of the synthesized 152.  
 
 
 
Synthesis of the methylene analog of tryptophan (165):115 Compound 165 was 
synthesized according to the previously reported procedure as shown in Figure 5.22. 
Briefly, in a dry round bottom flask, add 2 ml dry tetrahydrofuran (THF) and 130 mg (6 
mmol) Mg turnings. Under an inert atmosphere, add 650 mg (6 mmol) of ethyl bromide 
(188) dissolved in 2 ml THF. Stir on an ice bath for ~30 min after all Mg turnings have 
dissolved. Add dropwise solution of 590 mg (5 mmol) indole (132) dissolved in 2 ml 
THF and stir for 30 min. Dissolve 1 g (5.5 mmol) of methylbromomethacrylate (189) 
and add it drop wise. Remove the ice bath and stir at room temp for 30 min. Quench the 
reaction with water. Extract the aqueous phase with ethyl acetate and dry over MgSO4. 
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90:10). To hydrolyze the methyl ester of 190, dissolve the purified product in 5 ml of 
80% ethanol. Add 300 mg KOH and stir for 5 h at room temp. Then acidify the solution 
to pH 1 and extract the compound using diethyl ether. Purify 165 using flash 
chromatography (dichloromethane:methanol = 95:5). NMR was recorded in MeOD. 
 
 
 
 
A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.22: Synthesis and characterization of the methylene analog of tryptophan 
(165). A) Synthetic scheme. B) 1H-NMR of 165. C) 13C-NMR of 165. D) MS of 165 in 
negative mode. 
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6. SUMMARY AND OUTLOOK  
 
 The studies presented in this dissertation provide insights into the mechanistic 
work on three systems. Enzymes from a pathway that salvages L-cysteine from the S-
substituted cysteines were reconstituted. Studies on the unique flavoenzyme CmoJ 
suggest that it catalyzes Pummerer-type rearrangement. Structural studies on Riboflavin 
Lyase (RcaE) illustrate that the orientations of the cofactor FMN and substrate riboflavin 
play a critical role for this novel motif in flavin enzymology, which utilizes superoxide 
radical to initiate chemistry on the substrate. Biochemical studies on Tryptophan Lyase 
(NosL) have highlighted the mobility of the 5′-deoxyadenosyl radical and advanced our 
understanding on the fragmentation-recombination reaction involved in nosiheptide 
biosynthetic pathway. 
 
6.1 Cysteine salvage pathway 
Amino acid cysteine and the metabolites derived from it play a vital role in all 
forms of life. Recently, a pathway was identified in Bacillus subtilis that salvages 
cysteine from S-substituted cysteines. In our study, we have elucidated the function of 
all five enzymes in this pathway. It involves a unique Pummerer-type rearrangement 
catalyzed by a flavoenzyme CmoJ. Though the pathway shows broad substrate 
specificity, our studies indicate that S-benzyl substituted cysteines might be the 
physiological substrates of the enzymes. Though there are few reports on biosynthesis of 
such molecules in plants, a comprehensive study will shed more light on their 
occurrence and distribution. Bioinformatic analysis shows that this pathway is present in 
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various microbes associated with plants. This study provides insights into a novel 
pathway in the largely unexplored world of rhizosphere microbiome. 
 
6.2 Riboflavin catabolism 
 Strain Microbacterium maritypicum G10 was isolated from riboflavin rich 
environment and was shown to catabolize riboflavin to lumichrome and ribose. The key 
enzyme riboflavin lyase (RcaE) involved in this transformation expands the chemical 
repertoire of flavin superfamily. Structural studies on RcaE advance our mechanistic 
understanding on superoxide radical mediated transformation, a novel catalytic motif in 
flavin enzymology. Though we were unable to obtain the oxygen bound structure of the 
enzyme-cofactor-substrate complex, an oxygen molecule can be modeled near the C4a-
N5 region of cofactor FMN and C1′ of the ribose chain in riboflavin (Figure 3.8B). This 
demonstrates that RcaE exhibits a steric control to catalyze this innovative superoxide 
radical mediated transformation. Future experiments will demonstrate the distribution of 
this motif.  
 The pathway discussed here utilizes the ribose from riboflavin as a carbon source 
and does not degrade the alloxazine ring of lumichrome. This suggests that other 
organisms may have evolved pathways to utilize lumichrome as a potential source of 
carbon as well as nitrogen. Additionally, this study sets the stage for further studies on 
alternate riboflavin catabolic pathways, which were previously reported but the strains 
were lost. Screening of bacterial strains collected from the riboflavin production plant 
(DSM nutritional products, Germany) is currently underway in Begley lab to explore 
these hypotheses on riboflavin catabolism.  
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6.3 Tryptophan Lyase (NosL) 
 Radical SAM enzymes catalyze some of the most complex rearrangement 
reactions discovered in the biological world. Tryptophan Lyase (NosL) from the 
aromatic amino acid lyases sub-family involves a fragmentation-recombination reaction 
to generate 3-methyl-2-indolic acid from L-tryptophan. We have identified cyanide as a 
byproduct of this reaction and demonstrated that the 5′-deoxyadenosyl radical abstracts 
H-atom from the amino group of L-tryptophan. Mutagenesis studies show that Arg323 is 
important for controlling the regiochemistry of the β-scission reaction. Further studies 
with L-tryptophan thiocarboxylate and 2'-halo-L-tryptophan support the Cα-C(O) 
cleavage after H-atom abstraction. A revised mechanistic proposal consistent with all 
observations discussed and recently observed EPR spectroscopy data has been illustrated 
in section 4.4.11 (Figure 4.34). This study has uncovered an unanticipated connection 
between NosL and HydG – a radical SAM enzyme that forms cyanide and carbon 
monoxide from tyrosine during the biosynthesis of the metallo cluster of the [Fe-Fe]-
hydrogenase. 
 While investigating the mechanism of the NosL catalyzed reaction, we explored 
the reactivity of the 5′-deoxyadenosyl radical. We have demonstrated that the 
regiochemistry of H-atom abstraction can be altered, the chemistry can be changed from 
H-atom abstraction to double bond addition, attack of 5′-deoxyadenosyl radical to [4Fe-
4S] leads to enzyme inactivation and radical intermediates can be trapped by dithionite. 
This study highlights a plethora of transformations possible by the incredible 5′-
deoxyadenosyl radical, which is a common intermediate in most radical SAM enzymes. 
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